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 Successful pregnancy outcome is contingent on a number of factors, the earliest of 
which include the events occurring during early pregnancy.  This time period from 
fertilization to implantation requires drastic changes in both the embryo and the uterus, 
including cell proliferation and differentiation.  Alterations in pre-implantation milieu 
may lead to adverse effects during any of these stages.  This emphasizes the need to 
understand these early processes and the potential deleterious conditions that may be 
contributing to adverse pregnancy outcome including fetal malformations and demise.   
 In the second chapter, we provide evidence for a differential response of elevated 
activation of autophagy in embryos and oocytes exposed to a hyperglycemic 
environment, which is accompanied by an increase in apoptosis.  While this environment 
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signaled the activation of these pathways, a hyperglycemic environment during the pre-
implantation stage has previously been shown to also alter expression levels of facilitated 
glucose transporters (SLC2As).  One SLC2A in particular, SLC2A8, has been implicated 
as an important glucose transporter during early pregnancy events, however, a detailed 
study of this transporter during this time period has been lacking in the literature.  Using 
a Slc2a8 deficient mouse model, the data presented in third chapter is the first to 
demonstrate that a lack of Slc2a8 leads to reproductive defects most likely due to 
abnormal decidualization and impaired implantation.  This phenotype leads to decreased 
litter size, and smaller pups at weaning that continue to display an abnormally small 
growth phenotype into adulthood.  Furthermore, in chapter 4 we detail the novel finding 
of SLC2A8 co-localization with autophagosomes during autophagy activation in uterine 
stromal cells.  In conclusion, the findings in this dissertation support the hypothesis that 
alterations of the pre-implantation milieu during early pregnancy events can result in 
aberrations in processes directly impacting fetal outcome and the success of a pregnancy.   
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Introduction 
1.1 Early Pregnancy Events 
Crucial to the perpetuation of all species is the ability to reproduce.  Pregnancy 
encompasses the important events from conception to birth.  Full-term pregnancy is 40 
weeks in a human, however this time is significantly shorter in mice, 19-20 days, which 
along with other factors makes the mouse a good model organism to study pregnancy 
events[1].  Years of compounded studies highlight the importance of early embryonic 
development in pregnancy outcome and reproductive success.  These data emphasize the 
need to understand these early processes and the potential deleterious environments that 
may be contributing to fetal malformations and demise.  This section of the chapter will 
introduce the important events occurring during early pregnancy in mice, specifically the 
time period encompassing fertilization through implantation.   
1.1.1 Pre-implantation Events  
For the purpose of this manuscript, the pre-implantation time period of 
embryogenesis refers to the events that occur prior to the blastocyst invasion of the uterus.  
During this time the embryo will develop from a single cell into a multi-cellular structure 
with two distinct cell lineages.  Concurrent with embryo cleavage and the beginning of 
differentiation, the embryo will travel through the oviduct, as a result of peristaltic 
movement, to eventually reach the uterus where implantation will occur.  This whole 
process, from fertilization to blastocyst implantation lasts 4-5 days in the mouse, and 5 
days in the human[1, 2]. 
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While the pre-implantation period is considered to begin after fertilization, the 
contribution of the gametes should not be overlooked.  Evidence in the literature suggests 
the quality of the egg and sperm has a direct impact on the development of the embryo, 
implantation, fetal outcome and even adult disease[3, 4].  An overview of the female 
gametes, oocytes will be discussed, followed by a review of the male gamete 
development, sperm.   
Female mice are born with a finite number of oocytes; however, well over half of 
these will degrade during the first few weeks following birth[5, 6].  The oocytes that 
remain will be arrested in the diplotene stage of the first meiotic prophase until they are 
sexually mature, which is characterized by an increase in size and the competency to 
respond to hormonal stimulation[1].  Upon stimulation by follicle stimulating hormone 
(FSH), competent oocytes, making up only a few of the total population will respond by 
preparing for ovulation.  Ovulation is signaled by a surge of luteinizing hormone (LH).  
The pituitary secretes both FSH and LH, and this cycle is repeated every 4 to 5 days in the 
mature mouse[1, 7].   For experimental purposes, this process can be artificially induced 
and amplified in the mice by exogenous hormone (over)stimulation, making the mouse a 
valuable tool in the investigation of early pregnancy processes.     
Analogous to oogenesis, the process of spermatogenesis is reliant on pituitary 
gonadotrophins[8].  Unlike oogenesis, spermatogenesis is reliant on a self-renewing 
population of stem cells in the testes, taking around 35 days to complete the process from 
stem cell to spermatozoa[9].  Once copulation has occurred and the sperm are released 
into the female reproductive tract, the sperm will enter the oocyte, after several well-
characterized events and the oocyte will be fertilized in the distal oviduct.   
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Several factors can affect the quality of the gametes, including genetic, 
environmental and metabolic factors.  Of importance to this manuscript, diabetic 
conditions, including hyperglycemia, have been shown to lead to a poorer quality oocyte 
and sperm.  In the oocyte this is associated with reduced levels of ATP and necessary 
metabolites, resulting in poor reproductive outcomes[10, 11]. 
After fertilization, a series of cleavage events occur developing a single cell into 
over sixty cells with two differentiated cell lineages, these events are outlined in Figure 
1.1.  As the embryo travels from the oviduct to the uterus, it will continue to increase in 
cell number through cleavage events but remain the same size.  While mouse and human 
pre-implantation developments are similar, the following events will refer to specific time 
points within mouse development.  During these very early stages of development 
following fertilization, the embryo relies on maternal mRNA and protein that was 
synthesized during the period of oogenesis[12].  However, at the two-cell stage (12-36 
hours post-fertilization, hpf), the zygotic transcription is activated and the maternal 
constituents are degraded over the subsequent developmental stages[13].  Another 
cleavage event will take place resulting in 4-cells around 48 hpf and 8-cells shortly 
thereafter, around 60 hpf[1]. 
While the cells of the embryo remain equipotent to this point, the cells of the 
embryo begin to compact and polarize.  As the embryo develops into the morula stage 
(~70 hpf), it begins to differentiate into two distinct cell lineages, the inner cell mass 
(ICM) and the trophectoderm (TE).  Of these lineages that form, the inner cell mass, 
represents the cells that will go on to develop into the embryo.  The trophectoderm will 
surround the inner cell mass making up the periphery of the embryo and shield the ICM 
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from direct contact with the external environment.  These cells, referred to as trophoblasts, 
will go on to develop into the placenta later in pregnancy[1]. 
During these events leading to blastocyst development (~84-96 hpf); the embryo 
has relied on the metabolism of both lactate and pyruvate as main substrates for 
energy[14, 15].  However, concurrent with the hatching of the blastocyst in preparation 
for implantation, the embryo acquires the ability to perform glycolysis and relies on 
glucose as its main substrate[14, 16, 17].  An upregulation of glucose transporters is 
observed during this time, which will be described in detail later in this chapter.     
As mentioned previously, the overall quality of the embryo can be impacted by 
genetic, metabolic and even environmental conditions.  Of interest to this study, the 
literature has detailed the negative impact that obesity and hyperglycemia has on gamete 
and embryo quality, leading to a poor reproductive outcome[18, 19].  These metabolic 
conditions will alter gene expression leading to changes in fetal outcome[20, 21].  Overall, 
the events occurring during pre-implantation can be critical to the success of the 
pregnancy and overall fetal outcome.   
  1.1.2 Implantation and Decidualization  
The success of a pregnancy is also highly dependent on the subsequent processes 
of implantation and decidualization.  Implantation refers to the attachment and succeeding 
invasion of the embryo into the uterine wall.  The attachment of the embryo to the uterine 
wall, occurring 4.5 days after fertilization (E4.5) in the mouse, will signal the process of 
decidualization to begin[22].  This process includes differentiation and remodeling of the 
stromal cells of the uterus in order to become receptive to the implanting embryo[23].  
! T!
Both steps are highly dependent on complex signaling cascades regulated by the steroidal 
hormones, estrogen and progesterone[24].  These signals will bring about changes in the 
cell morphology and the biochemical properties of these cells, which will provide an 
environment that facilitates implantation.   Defects in these hormonal signaling cascades 
leads to an impairment in the decidualization process and oftentimes manifests as 
infertility[25, 26].   
Besides hormonal regulation, ongoing research suggests a critical role of glucose 
metabolism during decidualization[27].  This role for glucose utilization is supported by 
the upregulation of several glucose transporters in accordance with this event; with 
facilitative glucose transporter 1 exhibiting the highest response[28].  The importance of 
glucose transporters during these events will also be discussed later in this chapter.    
Activation of several genes central to decidualization occurs in both the mouse and 
the human.  These genes, although distinct between species, represent common markers of 
the decidualization process.  Increased amounts of bone morphogenetic protein 2 (Bmp2), 
prolactin-related protein (Prp) and cyclooxygenase 2 (Cox2) are observed in the mouse, 
while changes in prolactin (Prl), and insulin-like growth factor binding protein (Igfbp1) 
are evident in humans[29-33]. 
In summation, events occurring during early pregnancy have great impact on the 
outcome of the pregnancy.  Evidence in the literature suggests that the quality of the 
gametes has a direct impact on embryo quality.  Furthermore, the processes of 
implantation and decidualization are highly regulated and the success of the pregnancy 
depends greatly on the completion of these processes.  The importance of these processes 
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to pregnancy outcome highlights the need to continue to fully understand the mechanisms 
underlying them. 
1.2 Autophagy   
1.2.1 Autophagy Overview 
  Autophagy is a catabolic process by which long-lived proteins and damaged 
organelles are sequestered for degradation via the lysosome.  Three types of autophagic 
degradation have been described in the literature (1) microautophagy, (2) macroautophagy 
and (3) chaperone-mediated autophagy.  Microautophagy occurs as an invagination of the 
lysosomal membrane.  This is unlike the process of macroautophagy, which involves the 
sequestration of damaged organelles or long-lived proteins in double membrane 
structures, autophagosomes, which then fuse with lysosomes.  And lastly, chaperone-
mediated autophagy involves translocation of unfolded, soluble proteins across the 
lysosomal membranes[34-36].  For the purposes of this manuscript, the word autophagy 
will be used to refer to the process of macroautophagy.   
It is evident in the literature that autophagy is a critical pathway in a number of 
biological processes, such as cell growth, cellular homeostasis, and development[36, 37].  
Moreover, there is a clearly established role of autophagy as a protective process in 
response to environmental stress.  These stressors can include nutrient deprivation, 
oxidative stress, and infection[37].  Signaling pathways activated in these conditions 
closely regulate induction of autophagy.   In particular, the TOR pathway, which is 
activated during nutrient starvation and the RAS/camp/PKA pathway, which plays a role 
in glucose sensing, are important in autophagy induction[38, 39].  Other signaling 
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pathways, such as AMPK signaling also play a role[40].  Interestingly, while autophagy is 
initially activated for protective purposes, excess of autophagy can actually be toxic and 
result in cell death[41].  Furthermore, the process of autophagy may be altered in disease 
states, which can result in protective effects or even harmful effects[35].  These findings 
suggest that the process of autophagy must be highly regulated in normal states to 
maintain a threshold of autophagic activity.         
The process of autophagy involves a number of key players in a series of defined 
steps.  The steps in the autophagic pathway that this manuscript will focus on are vesicle 
formation and elongation, fusion, and the breakdown and recycling of the autolysosome 
contents.  These steps are detailed in Figure 1.2.   
The origin of the autophagosomal membrane is a highly debated topic in the 
current literature.  A number hypotheses have been considered, however two remain to be 
debated.  One is that the origin of the membrane is formed from the membrane of an 
intracellular organelle, namely the endoplasmic reticulum, the other hypothesis is that the 
membrane is synthesized de novo in the cytosol[42-44]. While both represent attractive 
hypotheses, sufficient data defining the source of the membrane has yet to be elucidated.  
It is known, however, that the induction of autophagy occurs via activation of the Atg1 
complex (ULK1 and ULK2, in mammals).  This complex acts to recruit other Atg proteins 
to what is known as the Phagophore Activation Site on the autophagosomal 
membrane[45-47].   The key players that aid in vesicle formation and elongation have 
been identified as Atg12/Atg8 complex (Atg12/LC3 in mammals), which is an ubiquitin-
like protein system, and the Atg16L complex, which aids in both elongation and closure 
of the autophagosome[48, 49].  These complexes continue to elongate the vesicle until it 
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has fully engulfed the contents to be degraded.  The outer membrane of autophagosome 
will then fuse with a lysosome and the inner membrane is subsequently degraded forming 
the autolysosome[50].  The long-lived proteins are degraded by lysosomal hydrolases and 
the amino acids are returned to the cytosol for use by the cell.  Although this process of 
recycling is not well characterized, it is believed that permeases are responsible for, at the 
least, amino acid recycling[50].  An interesting question that remains unanswered is: how 
do the carbohydrates and other macromolecules that remain get recycled back to the 
cytosol?    
1.2.2 Autophagy during Early Pregnancy Events 
  In recent years the importance of autophagy in normal biological processes, such 
as development, is becoming increasingly evident.  This section of the manuscript will 
focus on the role of autophagy in early pregnancy events.   
As mentioned previously, in both humans and mice, females are born with a finite 
number of oocytes.  A large number of oocytes are destroyed, however this attrition does 
not correspond with high levels of apoptosis in mice; instead it is hypothesized that 
autophagy contributes to this process, because an increase in autophagic markers are 
observed during this process[6]. 
While autophagy is not observed in unfertilized oocytes in sexually mature female 
mice, the published data suggests that autophagy is activated 4 hours after fertilization of 
the oocyte[51].  However, this expression wanes shortly after and then is reactivated at the 
two-cell stage[51].  The role for autophagy during this early time period of development is 
unknown, but there is speculation that autophagy may be activated in order to degrade 
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maternal proteins once the zygotic genome is activated (E2.0).   This hypothesis is 
supported by a developmental arrest between the 4-cell and 8-cell stage in an autophagy 
deficient model[52].  This indicates that proper autophagic degradation within early 
embryos is essential for progression of pre-implantation development.   
Recently published data suggests a role for autophagy during embryoid 
cavitation[53].  This group reported that loss of either Beclin-1 (required for the initiation 
of autophagosome formation) or Atg5 (a critical component to the formation of 
autophagosomes), both essential autophagic genes, leads to failure of cavitation due to the 
persistence of cellular corpses in murine embryonic stem cells.  These cells fail to display 
signals to indicate removal.  This dysregulation is also associated with low levels of 
ATP[53].  Overall, the lethality associated with removal of this pathway, indicates the 
critical roles that this pathway plays in embryo development, many of which may not be 
elucidated yet. 
In humans the timing of implantation is important for the success of the 
pregnancy, and implantation occurring more than 8 days after ovulation correlates to an 
increase in pregnancy loss in humans[54].  It has been suggested that autophagy may also 
play a role in this critical process.  Lee et al. reported that at the time of implantation in 
the mouse (E4.5) there is an increase of autophagosomes formed in the trophoblast cells of 
the blastocyst[55].  This differential response of autophagy during this critical time, 
mainly an upregulation in the placental cell lineage, indicates a potential role for 
autophagy in the implantation of the blastocyst.   
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In conclusion, many questions still remain about the role autophagy plays during 
early pregnancy events.  However, it is known that this process is occurring in both 
gametes and pre-implantation embryos and is upregulated during implantation in the 
trophectoderm of the blastocyst.  Furthermore, using knockout mouse technology, it has 
been determined that autophagy is necessary for pre-implantation development beyond the 
8-cell stage.  These data highlight the need for further studies investigating autophagy 
during early pregnancy events.   
1.3 Glucose Transporters 
1.3.1 Overview of Glucose Transporters 
  Glucose transport across membranes can be accomplished by either sodium-
coupled glucose transporters (SGLTs) or facilitative glucose transporters, known as the 
SLC2A family.  The SLC2A family (with members commonly referred to as GLUTs), is 
the family of solute carriers known to transport various hexose molecules across 
membranes.  This family is comprised of 14 members[56].  All 14 known SLC2As have 
shared characteristics including 12 transmembrane spanning helices and an exofacial N-
linked glycosylation site, however, each SLC2A family member is unique in regards to 
tissue localization, kinetics and substrate specificity[56].   
The 14 members of the SLC2A family are divided into three classes, Class I, II 
and III.  Class I is comprised of SLC2As 1-4 and 14.  Often referred to as the classical 
transporters, this class of glucose transporters was the first to be described in the literature 
and has since been the most well studied of the family.  Typically, these transporters are 
either localized to the cell surface, such as SLC2A1, or shuttled to the cell surface from an 
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intracellular compartment in response to signal, such as insulin or high glucose, as in the 
case of SLC2A4, to aid in whole body glucose homeostasis[56]. 
Class II, or the “odd” transporters, consists of SLC2As 5, 7, 9, and 11.  Consistent 
with Class I SLC2As, these facilitative glucose transporters have their N-linked 
glycosylation site positioned in the exofacial loop between helices 1 and 2.  However, this 
class of transporters are unique as they are able to transport fructose[57].  While SLC2A5 
and SLC2A7 are found primarily in the intestine, SLC2A11 has a much wider distribution 
pattern.  And SLC2A9 is widely recognized as a transporter of uric acid and has been 
shown to play a key role in urate homeostasis[58]. 
   Lastly, Class III, or the “even” transporters encompasses SLC2As 6, 8, 10, 12 
and the proton myoinositol transporter or SLC2A13.  Unlike, Class I and II, the N-linked 
glycosylation site in Class III transporters is not in the first exofacial loop but rather in the 
fifth loop.  Intriguingly, another unique characteristic is the retention of these SLC2As to 
an intracellular location, which has been attributed to the presence of an internalization 
signaling motif[59].  While the majority of these glucose transporters have not been well 
studied, research is ongoing to characterize these SLC2As.   
Dysregulation of glucose transporters often results in adverse metabolic 
conditions, as implied by their function.  While manipulation of SLC2A gene expression 
results in a variety of severity in phenotypes in mice, in humans four known inherited 
syndromes have been linked to mutations in the genes of SLC2A family members to 
date[56].  Notably, GLUT-1 deficiency syndrome causes infantile seizures, microcephaly 
and a delay in development due to a decrease of glucose transport across the brain-blood 
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barrier[60].  Another condition is Fanconi-Bickel Syndrome, which is caused by 
mutations in SLC2A2 resulting metabolic dysfunctions along with hepatomegaly and 
dwarfism[61].   These adverse outcomes reveal a necessity for a clear understanding of the 
role of each facilitative glucose transporter in physiological events.   
1.3.2 Glucose Transporter 8 
Glucose Transporter 8 was the first SLC2A identified by database mining and was 
determined to have 44% sequence similarity to SLC2A5[62].  A member of the Class III 
SLC2As, SLC2A8 has the shared features of a N-glycosylation site on the fifth 
extracellular loop and a intracellular localization, which is signaled by a dileucine motif 
(DEXXXLL), trafficking SLC2A8 to the late endosome/lysosome[59].  In order to 
determine affinity for glucose, Xenopus oocyte glucose uptake studies are used.  In these 
studies, the Slc2a8 gene must be manipulated by changing an amino acid in the 
intracellular localization signal to allow for SLC2A8 to be translocated to the plasma 
membrane.  These studies have suggested that SLC2A8 has a high affinity for glucose, 
with a Km~2[63].  Additionally, transport of glucose in this system by SLC2A8 can be 
competed out with the addition of fructose or galactose, suggesting that SLC2A8 may 
transport these and potentially other hexoses.  Additionally, glucose transport by SLC2A8 
can be blocked by the addition of cytochalasin B, a known glucose transport inhibitor[63].  
Research on this SLC2A is ongoing, particularly concerning physiological function of 
SLC2A8. 
Expression profiling of SLC2A8 has revealed a wide distribution of this 
transporter with the most abundant expression exhibited in the testes.  SLC2A8 is also 
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expressed in other reproductive tissues such as the ovary and uterus, in addition to various 
other tissues including the brain, liver, adipose, and heart.  It is also present in the 
blastocyst[63].     
Due to the expression of SLC2A8 in reproductive and embryonic tissues, it was 
speculated to have a role in early pregnancy events.  In fact, while SLC2A8 is not known 
to be present at the cell membrane in any of the investigated cell types, there is data to 
support its translocation to the plasma membrane in blastocysts in an insulin responsive 
manner[64].  This data suggests a possible novel role for SLC2A8 in glucose utilization 
during blastocyst development and reflects the unique environment in embryonic stem 
cells.  Furthermore, knockdown of Slc2a8 in the embryo, by anti-sense technology, 
resulted in an increase of cell death in blastocysts and a decrease in successful pregnancies 
by E14.5[65].  Again, this supports the hypothesis that SLC2A8 is critical for normal 
embryonic development.   
While data obtained from blastocyst studies predict a requirement of SLC2A8 in 
normal embryonic development, two published Slc2a8 deficient models do not exhibit 
embryonic lethality as expected.  This unexpected finding could be attributed to knockout 
strategy, as both models of Slc2a8 deficient mouse models were created by 
unconventional strategies.  Membrez et al. created a conditional mouse, which expressed a 
truncated form of the SLC2A8 protein.  This group targeted exon 10, the last exon of the 
Slc2a8 gene, by flanking it with loxP sites and crossed lox-positive mice with NesCreI 
mice, which express Cre recombinase driven by the Nestin promoter.  The use of the 
alternative, NesCreI mice, was supported by literature reporting activation of Nestin in the 
germ line.  The authors acknowledge that this results in a truncated SLC2A8 protein, 
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which was determined to be non-functional.  Studies to determine functionality are were 
conducted using Xenopus uptake assays, which require a mutation in the intracellular 
localization for retention to the plasma membrane along with the deletion of exon 10[66].  
A second group, Gawlik et al., constructed a targeting site flanking exons 5-7 with loxP 
sites and introducing this by homologous recombination into embryonic stem cells (ES).  
The ES cell clones, which had successfully incorporated the targeted allele, were 
transiently trasnfected with pCre to generate ES clones with a deleted allele, which were 
used for morula aggregration and the resultant blastocysts were transferred to a 
pseduopregnancy female mouse[67].  However, the resultant Slc2a8-/- mice were only 
shown to not possess the full length mRNA by quantitative RT-PCR and not by 
conventional standards of Southern Blot.  Therefore, due to the alternative strategies 
employed and inadequate published verification of non-functional SLC2A8 protein in 
these Slc2a8-/- mice, careful consideration must be taken when reviewed the resultant 
phenotypes.  
While neither group observed embryonic lethality, both groups noted that the 
heterozygous mating of Slc2a8 mice resulted in lower than expected percentage of 
Slc2a8-/- and Slc2a8+/- pups[66, 67].  Gawlik et al. attributed this phenotype to an 
observable reduction in sperm motility[67].  Investigation into the reproductive phenotype 
revealed a decrease in mitochondrial membrane potential leading to decreased ATP levels 
and a reduced sperm motility[67].  Overall, the authors hypothesized the lower than 
expected number of homozygous null and heterozygous pups in the heterozygous matings 
to the possibility of the Slc2a8-/- sperm being slower to reach the egg.  However, this is 
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unlikely, as the time necessary in the uterine tract for the sperm to even become 
competent for fertilization is around an hour[1].  
Other notable phenotypic observations includes a mild brain phenotype consisting 
of increased proliferation of hippocampal cells and an increased P-wave duration in the 
heart, in the mouse model created by Membrez et al.[66]. And several behavioral 
alterations, including hyperactivity in the previously mentioned mouse model with 
reduced sperm motility[68].  All of these phenotypes are not surprising as SLC2A8 is 
highly expressed in the testes and expressed to a lesser extent in the brain and heart.  Of 
note, neither of these groups reported changes in normal glucose homeostasis or growth at 
baseline in these models.   
Overall, in the field of glucose transport, questions surrounding the function of 
SLC2A8 still remain unanswered.  However, the combination of data obtained by in vitro 
and in vivo studies, suggest an importance of SLC2A8 in several processes, including 
embryonic development, sperm functionality, normal neuronal activities and normal heart 
function.  These findings emphasize the need for a clear understanding of the role of 
SLC2A8. 
1.3.3 Glucose Transporters in Early Pregnancy Events 
   1.3.3.1 Glucose Transporters in Pre-implantation Events 
As the gametes and the embryo journey from the oviduct to the uterus, and 
progress from a single cell into a blastocyst, they are subjected to a variety of 
environments.  This requires the gametes and the embryo to be able to adapt to these 
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differing surroundings.  One way in which they accomplish this is by utilizing of a variety 
of glucose transporters during these processes.   
As previously mentioned, the oocyte and early embryo exhibit a low level of 
glucose consumption, as pyruvate is the main energy source.  However, of the facilitative 
glucose transporters that have been investigated, several are expressed in the oocyte of the 
mouse, including SLC2A1, 7, 9 and 13[69-71].  Additionally, conditions that lead to 
abnormal glucose transporter expression, such as hyperglycemia and hyperinsulemnia, 
have suggested a need for normal glucose transporter expression in oocyte progression 
and function.  This is evident from studies using oocytes obtained from mouse models of 
Type I diabetes.  These oocytes are smaller and exhibit a delayed maturation[72].  
Additionally exposure to this aberrant metabolic milieu for merely 24 hours after 
fertilization will lead to detrimental fetal outcomes.  This is evident in a study conducted 
by Moley et al., in which fertilized oocytes from diabetic female mice were transferred 
into pseudo-pregnant control mice.  The resultant fetuses showed an increased incidence 
of malformations and growth retardation when compared to fetuses obtained from 
transferring control oocytes into pseudo-pregnant control females[73].  This data along 
with previous studies which report a decrease in glucose transporter expression during 
diabetic conditions in the blastocyst, suggests that normal glucose transport is critical to 
normal development at very early stages of pregnancy and that alterations in this function 
leads to an increase in poor fetal outcome[20].  
Previously, a role for SLC2A8 in energy metabolism of the sperm was addressed.  
While the function of glucose transporters in sperm remains elusive, we are able to 
understand a need for normal glucose transporter expression in the male reproductive 
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tissue by examining situations in which this expression is disrupted[74].  For example, in 
a mouse model of Type I diabetes, the mice exhibit a decrease in sperm concentration, 
motility and fertilization[74].  Additionally, in human studies, fertilization rates and 
progression to blastocyst development are decreased.   Both of these studies reflect the 
importance of glucose homeostasis in normal sperm development and highlight the need 
for ongoing research in this field[74].   
Briefly alluded to previously, facilitative glucose transporters have been shown to 
be important in embryogenesis in the mouse model.  Several SLC2As are expressed at 
various stages of pre-implantation development and alteration of the expression of these 
SLC2As, either by genetic means or metabolically, results in deleterious effects on the 
embryo.  This section will detail the current field of SLC2As in pre-implantation 
embryogenesis.   
  Of the facilitative glucose transporters that have been studied, several have been 
identified in the mouse in various stage of pre-implantation development, including 
SLC2As 1-4, 8, 9 and 12.  Using mouse models of glucose transporter knockdown or 
knockout, we are able to investigate the role of these glucose transporters in reproduction.     
SLC2A1 is expressed throughout pre-implantation embryogenesis[75].  However, 
SLC2A1 expression remains cytoplasmic until the morula stage when the embryo is 
polarized, at this time GLUT1 is localized to basolateral membrane of the trophoblast and 
the plasma membrane of the ICM, presumably to transport glucose into the ICM(Figure 
1.3)[75, 76].  Deletion of SLC2A1 does not result in embryonic lethality, however the 
Slc2a1-/- mice exhibit lethality around E13[77].  Survival of the fetuses to this later stage 
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in development indicates SLC2A1 is not required for pre-implantation embryonic 
development to occur or that possibly another SLC2A is able to compensate for the loss.  
SLC2A2 is also found basolaterally in the trophoblast cells of the mouse.  This transporter 
represents an inefficient transporter in the low glucose environment due to its high Km 
value (~20mM)[78].  Therefore, it may represent either no function or a compensatory 
mechanism for SLC2A1 loss.  Furthermore, conventional global knockout of Slc2a2 in 
mice does not produce embryonic lethality, however, the mice develop symptoms of Type 
II diabetes and die shortly after birth, indicating a role in whole body glucose 
homeostasis[79]. 
SLC2A3 is found in both human and mouse starting during compaction, around 
the 8-cell stage[80].  SLC2A3 is a high capacity transporter and is often found in tissues 
which require an abundance of glucose.  Contrary to SLC2A1 and SLC2A2, SLC2A3 is 
found on the apical membrane, indicating a possible role in delivering glucose from the 
maternal environment[80].  Deletion of Slc2a3 by gene trap results in demise of Slc2a3-/- 
fetuses by E12.5.  Another model of Slc2a3 deficiency by conventional knockout of 
Slc2a3, results in an increase in apoptosis in the trophectoderm and overall demise of the 
embryo by E9.5.  In this Slc2a3-/- mouse model, diffuse SLC2A1 expression was 
observed, as opposed to the normal expression pattern at the basolateral membrane in 
trophoblast cells[81].  The presence of another facilitative glucose transporter, SLC2A4 in 
pre-implantation embryos remains controversial in the literature, and deficiency of this 
gene in mice does not present with defects in reproduction[82, 83].   
As previously discussed in the last section, SLC2A8 expression is localized to the 
apical plasma membrane in the trophoblast cells in response to insulin and knockdown of 
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SLC2A8 by anti-sense technology led to an increase in apoptosis[64].  Transfer of these 
treated embryos to pseudo-pregnant females resulted in decreased pregnancy rate and a 
high rate of resorptions[65].  However, surprisingly, knockout of Slc2a8 in the mouse did 
not result in embryonic lethality in two published models.  However, as mentioned 
previously, this may be a result of the unconventional strategies employed in the creation 
of the mouse.  SLC2A9 has also been investigated in the mouse.  It is expressed during the 
one-to-two cell stage and again later in the blastocyst intracellularly.  By blocking Slc2a9 
expression by antisense technology and transferring the embryos into pseudo-pregnant 
females, Carayannopoulos et al. were able to show the importance of SLC2A9 in 
embryogenesis, as rates of pregnancy were decreased[84].  Lastly, SLC2A12 is seen very 
early in development, with expression apparent in the oocyte and two-cell embryo 
however this expression lessens around E3[85].  Further studies are warranted to fully 
understand the role these facilitative glucose transporters represent in pre-implantation 
embryonic development. 
1.3.3.2 Glucose Transporters in Implantation and Decidualization 
Uterine decidualization is a remarkable process that requires the differentiation of 
a population of uterine cells, the stromal cells.  Several studies have indicated the 
importance of glucose metabolism during decidualization[28, 86-88].  Recently, Frolova 
et al. reported that culture conditions of low glucose resulted in impaired decidualization 
in both mouse and human in vitro endometrial stromal cell cultures[28].  Furthermore, the 
increase of facilitative glucose transporter expression during this critical time window for 
decidualization indicates a requirement of glucose utilization to complete the 
decidualization process[28, 87, 88].      
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Of the glucose transporters that have been investigated, several SLC2As are 
expressed in the uterus during decidualization in both mice and humans, including 
SLC2A1, 3, 6, 8, 10, and 12[28].  Expression of SLC2A2, 4, and 5 are either not 
expressed (SLC2A2) or expressed at almost undetectable levels (SLC2A4 and 5).  While 
several SLC2As are present during decidualization, only a few are shown to increase 
concurrent with the decidualization process.  In mice SLC2A1, 6 and 8 exhibit significant 
increase in mRNA copy number during this process in vitro.  In human in vitro 
endometrial stromal cell culture, SLC2A1, 8, 10 and 12 exhibit increased mRNA copy 
number upon decidualization[28].     
In both mice and human, SLC2A1 represents the most abundant facilitative 
glucose transporter with the highest fold increase of the SLC2As during 
decidualization[28, 87].  Frolova et al. demonstrated the importance of this SLC2A during 
decidualization by using lentivirus shRNA technology to knockdown Slc2a1 in human 
endometrial stromal cells.  This deficiency in SLC2A1 led to a significant decrease in 
decidualization marker expression, suggesting a major role for SLC2A1 in the 
decidualization process.  Furthermore, compensation for loss of SLC2A1 was not evident 
based on expression of the other SLC2As, indicating a specific role for SLC2A1 in this 
process[28].  Overall, this indicates a unique and critical role for SLC2A1 in 
decidualization.     
The only other SLC2A to exhibit an increase in mRNA copy number upon 
decidualization in both mice and humans is SLC2A8[28].  Unlike, SLC2A1 which is 
localized specifically to the basolateral surface to presumably transport glucose into the 
stromal cells, SLC2A8 is found in high- and low- density intracellular membrane fractions 
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using cellular fractionation of mouse endometrial stromal cells[89].  This localization is 
concurrent with reported intracellular localization of SLC2A8 in other cell types[59, 90].  
These distinct localization patterns suggest differing roles for these SLC2As in the uterus 
and warrant further studies to elucidate the role of SLC2A8 during decidualization.      
In conclusion, the decidualization process requires an abundance of energy to 
undergo the functional and morphological changes involved in preparation of the uterus 
for the implanting blastocyst.  One important energy source for this transformation is 
glucose.  The need for glucose during this process is evident by the increased abundance 
of SLC2As during decidualization.  In particular, SLC2A1 has been identified as the most 
abundant SLC2A, and expression of this transporter is critical for proper uterine 
decidualization.  However, further studies are warranted to determine the role of several 
other SLC2As that are expressed during this time, in particular SLC2A8. 
 
In summation, events occurring during the pre-implantation period are critical to 
fetal outcome and the success of a pregnancy.  Aberrations in this process can arise from 
alterations of glucose transport, both by genetic and metabolic means.  These potentially 
detrimental outcomes reinforce the need for a clear understanding of the role of glucose 
transport in early pregnancy events. 
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1.5 Figure Legends 
Figure 1.1.  Pre-implantation stages of development in the mouse.  Upon fertilization 
of the oocyte in the oviduct, the developing embryo travels toward the uterus while 
undergoing several cell cleavages.  After entering the uterine cavity, at about 4.5dpc, the 
blastocyst will hatch and begin implanting in the uterine wall. 
 
Figure 1.2.  A schematic of autophagy in mammals.  Several autophagic proteins are 
recruited to the phagosome activation site (PAS) during autophagy initiation including the 
ULK1/2 complex.  The Atg12-Atg5-Atg16L complex along with LC3-II aids in 
phagopore elongation to form the enclosed autophagosome.  The autophagsome then fuses 
with the lysosome, and lysosomal enzymes degrade the internal membrane and 
autolysosomal contents.  Recycling of the amino acids to the cytosol is performed by the 
lysosomal permeases.    
 
Figure 1.3.  Glucose transporter localization in murine blastocysts.  SLC2A1 is 
localized to the basolateral membranes of the trophophectoderm in the murine blastocyst, 
while SLC2A3 is localized on the apical membranes.  The localization of SLC2A8 is 
unique in blastocysts as it is translocated to the plasma membrane of the trophoblast cells 
in response to insulin. 
 
! QS!
Figure 1.4.  Glucose transporter localization in endometrial stromal cells.  SLC2A1 is 
the most abundant facilitative glucose transporter present in the endometrial stromal cells 
(ESC) of the uterus, followed by SLC2A3 in the mouse.  These SLC2As are localized to 
the plasma membrane of ESCs.  SLC2A4 a well-characterized insulin-responsive SLC2A, 
is reported at almost undetectable levels.  Localization of SLC2A8 is unknown, however it 
has been localized intracellularly to either the endoplasmic reticulum or lysosome in other 
tissues. 
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ZE=e]!%0)"#")3<!4/"0/!/%7!(*0*8)-3!@**8!7,''*7)*2!%7!%8!%0)"#%).(!.+!)/*!%,).1/%'"0!
1%)/4%3:! !I,()/*(&.(*<! ")!%11*%(7! )/%)! )/*!%,).1/%'"0!1%)/4%3!&%3!@*!%-)*(*2!%7!
*%(-3! %7! )/*! ..03)*7! %7! %! (*7,-)! .+! &%)*(8%-! 2"%@*)*7:! ! A/"7! *%(-3! %-)*(%)".8! "8!
%,).1/%'3! &%3! (*7,-)! "8! 0/%8'*7! "8! i,%-")3! .+! )/*! *&@(3.! %+)*(! +*()"-"^%)".8:!!
].4*#*(<! +,()/*(! 7),2"*7! 4"--! 8**2! ).! @*! 0.82,0)*2! ).! #%-"2%)*! )/"7! /31.)/*7"7:!!
>#*(%--<!.,(!2%)%!7,''*7)7!)/%)!)/*!/31*('-30*&"0!*8#"(.8&*8)!-*%27!).!%8!"80(*%7*2!
%0)"#%)".8! .+! %,).1/%'3! 2,("8'! )/*! ..03)*! '(.4)/! 1/%7*! %82! 1(*H"&1-%8)%)".8!
2*#*-.1&*8)! (*7,-)"8'! "8! %!2"++*(*8)"%-! (*71.87*!@3! )/*! "82"#"2,%-! 0*--7!4")/"8! )/*!
*&@(3.:!!!!!
.
8I?.!"#$%&'()*(+($,-.
A/*! %,)/.(7! 4.,-2! -"5*! ).! %058.4-*2'*! 6%823! M*%))3! "8! )/*! ;.-*0,-%(!
;"0(.@".-.'3! $&%'"8'! I%0"-")3! %)! 6%7/"8').8! 98"#*(7")3! "8! K):! G.,"7! +.(! )/*!
)(%87&"77".8! *-*0)(.8! &"0(.70.13! "&%'"8'! %82! A/*! M%5*4*--! Y*,(."&%'"8'!
G%@.(%).(3!+.(!)/*!,7*!.+!)/*!0.8+.0%-!&"0(.70.13!+.(!"&%'"8':!
! SW!
8I>.2(U(G($"(-!
!#HVH&H.WN.X%+HVH#J.;N.;LJ+%+<GH.WN.1(GH-H#J.MN.Y%<.ZN.1H#H$%.WN.0H*HJ.1.R.
X%+<G%. /! PXXR! e"1/)/*("%! ).B"8H"82,0*2! %,).1/%'"0! 0%(2".&3.03)*! 2*%)/!
1-%37! %! 1%)/.'*8"0! (.-*! "8! &.,7*! &.2*-! .+! /*%()! +%"-,(*:! f$ R"2.$ :014! 8C@!
ROXWSHROOXQ:!
!#J.1N.ZH+H*<"LJ.XN.M<[J+J\H.1.R.KJV<#H+J.Z!PXXQ!=/.71/."8.7")"2*!QH5"8%7*!
%00*-*(%)*7! %,).1/%'"0! 0*--! 2*%)/! 2,("8'! '-,0.7*! 2*1("#%)".8! "8! )/*! (%)!
0%(2".&3.03)*H2*("#*2!0*--!-"8*!]W0P:!?,#2/1,1!88!VSPWHVSQS:!
!+L(G),.KN.WHGGJ-.]N.2($%').!9N.3G"J.^.R.5$*(G.2W!OWUR!]*1%)"0!%,).'(%1/3!"8!
,80.8)(.--*2! *B1*("&*8)%-! 2"%@*)*7! %82! ")7! (*-%)".87/"17! ).! "87,-"8! %82!
'-,0%'.8:!f$:.",$B,>1!%!?D!OVVHOWQ:!
P%\H. _N. `%$VH'(V:_%'%. 2!N. 6H-HG(-. 0N. _(GU(,,J$J. O^N. 4(--($. _N. ^HG%"L(,,(. 0N.
K(,JaJ(G.4N.K('(\.4N.;%<b<(G(.;N.Z%-LJ+%GJ.1N._J(GG%$.`N.6%)%*$%._.R.
XG%(+(G.`!PXXS! $8/"@")".8!.+!&%0(.%,).1/%'3! )("''*(7!%1.1).7"7:!+2.$:1..$
R"2.!8?!OXPSHOXRX:!
PG%&$. OO. R. cLJ,,J$*LH+. 4`! OWWO! A/*! (.-*7! .+! 13(,#%)*<! -%0)%)*! %82! '-,0.7*!
2,("8'! 1(*"&1-%8)%)".8! 2*#*-.1&*8)! .+! *&@(3.7! +(.&! IO! /3@("2! &"0*! "8!
#")(.:!Q1>1.2-41,%!AA8!WWHOXS:!
6(""%$J. MN. _JH"($,J$J. K. R. MJ+JH. `K! PXXV! A/*! "8#.-#*&*8)! .+! 0*--! 2*%)/! %82!
7,(#"#%-! "8!8*,(%-!),@*!2*+*0)7F!%!2"7)"80)!(.-*!+.(!%1.1).7"7!%82!%,).1/%'3r!
:1..$Q1(%0$Q";;1'!A?!OOUXHOOUU:!
! TX!
6LH$*. !;N. 4H'(. !0. R. K%'(\. XW! PXXS! ;%)*(8%-! 2"%@*)*7! %2#*(7*-3! %++*0)7!
1(*.#,-%).(3!..03)*!&%),(%)".8<!2*#*-.1&*8)<!%82!'(%8,-.7%!0*--!%1.1).7"7:!
3,)2#'",2.2/6!AD>!PRRSHPRSQ:!
6LJ. KKN. W%(L$. !. R. K%'(\. XW! PXXP! ;*)%@.-"0! 0/%8'*7! "8! )/*! '-,0.7*H"82,0*2!
%1.1).)"0! @-%7).037)! 7,''*7)! %-)*(%)".87! "8! &").0/.82("%-! 1/37".-.'3:! 84$ f$
G06!"2.$3,)2#'",2.$+1%(5!87B!JPPTHPQP:!
6%'(''.!N.2J""J. O9N.1HJ,. ;N.KJ'H-,H.;N.KH<G(G.5N.P%<"LJ(G:WH\(-.^N. MJ,V*(GH')._N.
`<J%:6HGGJ%$.!N.cH,(GL%<-(.0ON.^J.6cN.KHGJ.PN.PHGFG\._N.0(&+(\(G.44N.
P((G(.WK.R.`G(($.42!PXXU!ZE=e]!%82!%,).1/%'3!1(*7*(#*!7,(#"#%-!%+)*(!
%1.1).)"0!03).0/(.&*!0!(*-*%7*!"8!)/*!%@7*80*!.+!0%71%7*!%0)"#%)".8:!:1..!A8@!
WVQHWWU:!
6%%=(G.!.;2N.P%(L'(.XN.2J'(\.ON.K%'(\.XI.8EE7I!E,).1/%'3!"7!%!1/37".-.'"0!1(.0*77!
(*',-%)*2!@3!'-,0.7*!%#%"-%@"-")3!"8!)/*!&,("8*!1(*"&1-%8)%)".8!@-%7).037):!$8!$
D1-'2)&#%">1$W#"1,#1!$NW&--.141,%O!A<!11:!UQE:!
MJ+JH. `KN. ;,%\#%aH. !N. 2%+H*$%'J. !N. `J<$,H. ^N. 4J. PHG,%'%+(%. ;N. 0HG)H""J. 2N.
6%GHVVHGJ. KN. M<%"%. 6N. 5"HG. !N. ;"L&HG,V. _N. `G<--. _N. _JH"($,J$J. KN.
6L%&)L<G\. X. R. 6(""%$J. M! PXXU! E&@(%O! (*',-%)*7! %,).1/%'3! %82!
2*#*-.1&*8)!.+!)/*!8*(#.,7!737)*&:!L(%&'1!DDC!OOPOHOOPS:!
M<[J,H$J. ZN. XH&H+%GJ. 2.R.cH,H)H.W! PXXW! A/*! (.-*! .+! %,).1/%'3! "8! 1%80(*%)"0!
@*)%H0*--!%82!2"%@*)*7:!8&%2-0(/6!?!PVXHPVP:!
! TO!
`G<$(. 1N. K(G#(G. XN. ;H$)J*. `. R. 4HaJ(-. XO! PXXQ! K*-*0)"#*! 2*'(%2%)".8! .+!
.B"2%)"#*-3!&.2"+"*2!1(.)*"8!7,@7)(%)*7!@3!)/*!1(.)*%7.&*:!R"2#014$R"2-06!$
D1!$:244&,!BE?!UXWHUOV:!
`<H',J(GJ.2N. /H""HGJ$%.KN.K%''%.]N._GJ-"%.KN. /H""HGJ$%.;.R.1H'(aJ.2! PXXW!K-.4!
0..-"8'!.+!/,&%8!..03)*7F!,-)(%7)(,0),(%-!"8g,("*7!%82!%1.1).)"0!7)%),7:!@1'%".$
W%1'".!@A!OXPQHOXQR:!
O<$*L(J+.9;N.;"L%(''(G.9^N.KHGb<HG).X^N.^%<)($.94N.;"LHUU(G. O9.R.K%'(\.XW!
PXOX!e"*)H"82,0*2!.@*7")3!&.2*-F! %@8.(&%-! ..03)*7! %82!1*(7"7)*8)! '(.4)/!
%@8.(&%-")"*7!"8!)/*!.++71("8':!3,)2#'",2.2/6!A?A!RXQWHRXRT:!
XJUUJ$.2N.PH$)\%=H)L\H\.5.R.6<(Ga%.!K! PXXT!>B"2%)"#*! 7)(*77! %82! %,).1/%'3:!
8,%"2F")$D1)2F$W"/,(.!7!OSPHOTP:!
^(H. 2`N. K"6GH"#($. O9N. K"/$,\G(. ;;N. ;+J,L. c. R. PHJG). O4! OWWT! e"7),(@*2!
2*#*-.1&*8)! .+! )/*! 1(*"&1-%8)%)".8! *&@(3.! "8! )/*! "87,-"8H2*1*82*8)!
2"%@*)"0!MM_J!(%):!Q"(51%1!!D?!ORTQHORUX:!
^((-(. WO! OWWO! ;*)%@.-"7&! .+! )/*! 1(*"&1-%8)%)".8! &%&&%-"%8! *&@(3.:! ?F;$ D1>$
D1-'2)$R"2.!AB!QSHUP:!
KHJ<GJ.K6N.YH'"#aHG.9N.XJ+"LJ.!.R.XG%(+(G.`!PXXU!K*-+H*%)"8'!%82!7*-+H5"--"8'F!
0(.77)%-5!@*)4**8!%,).1/%'3!%82!%1.1).7"7:!L(%$D1>$+2.$:1..$R"2.!7!UROHUSP:!
KH-J$J. KN. P<*'JH$J. KN. ^<=J. 2N. )('. `<(GGH. ;N. P%**J. 5N. MJ'J==%$J. MN. KHG-(''J. ^N.
KH-J(''%. _. R. KHG"L(,,J. _! PXXW! E,).1/%'3! "8! /,&%8! )31*! P! 2"%@*)*7!
1%80(*%)"0!@*)%!0*--7:!Q"(51%2.2/"(!?8!OXVQHOXVT:!
! TP!
KJV<-LJ+H.0N. ZH+H+%,%.!N.KH,-<J.KN. Z%-LJ+%GJ. 1.R.3L-<+J. Z! PXXR! $8! #"#.!
%8%-37"7! .+! %,).1/%'3! "8! (*71.87*! ).! 8,)("*8)! 7)%(#%)".8! ,7"8'! )(%87'*8"0!
&"0*!*B1(*77"8'!%!+-,.(*70*8)!%,).1/%'.7.&*!&%(5*(:!+2.$R"2.$:1..!A?!OOXOH
OOOO:!
K%'(\. XWN. 6LJ. KKN. X$<)-%$. 6KN. X%G-+(\(G. ;O. R. K<("#'(G. KK! OWWV%!
]31*('-30*&"%! "82,0*7!%1.1).7"7! "8!1(*H"&1-%8)%)".8!*&@(3.7! )/(.,'/!0*--!
2*%)/!*++*0).(!1%)/4%37:!L(%$+1)!D!ORPOHORPR:!
K%'(\.XWN.6LJ.KK.R.K<("#'(G.KK!OWWV@!;%)*(8%-!/31*('-30*&"%!%-)*(7!'-,0.7*!
)(%871.()! %82! ,)"-"^%)".8! "8! &.,7*! 1(*"&1-%8)%)".8! *&@(3.7:! 84$ f$ G06!"2.!
8C?!JQVHRU:!
_H+=U(G. ;! PXXX! E1.1).7"7! "8! (.2*8)! 1*("H"&1-%8)%)".8! *&@(3.7F! 2"++*(*8)"%-!
7,70*1)"@"-")3! .+! "88*(! 0*--!&%77! %82! )(.1/*0).2*(&!0*--! -"8*%'*7HH%! (*#"*4:!
G.(#1,%(!8A.;<=='.!!KQHOX:!
_H+=U(G. ;N. ]H$)(GL(\)($. /N. K"6GH"#($. O9N. ](-('H. O. R. 4(. W(G,%*L. 2! OWWU!
$80(*%7*2!0*--!2*%)/!"8!(%)!@-%7).037)7!*B1.7*2!).!&%)*(8%-!2"%@*)*7!"8!,)*(.!
%82!).!/"'/!'-,0.7*!.(!),&.(!8*0(.7"7!+%0).(H%-1/%!"8!#")(.:!Q1>1.2-41,%!A8D!
RVPUHRVQT:!
_H--%$$(H<.O^N.3WI!OWWQ!3,J64(%"#$8,(.6!"!:!A.).4%<!YaF!],&%8%!=(*77:!
d<.eN.Y%<.YN.;<$.dN.^<F\:_L('=-.XN.6L($*._N.W%*H$.20N.`J'=J$.6.R.^(aJ$(.P!PXXU!
E,).1/%'3! '*8*H2*1*82*8)! 0-*%(%80*! .+! %1.1).)"0! 0*--7! 2,("8'! *&@(3.8"0!
2*#*-.1&*8):!:1..!A87!WQOHWRT:!
! TQ!
2%)GJ*<(V:9$GJb<(V. ;N. W(. ^. R. ^(+H-,(G-. OO! PXXR! \.-*! .+! &").0/.82("%-!
1*(&*%@"-")3!)(%87")".8!1.(*7!"8!&").0/.82("%-!%,).1/%'3:!B,%$f$R"2#014$:1..$
R"2.!B>!PRTQHPRUP:!
;H#HJ)H./N.X\'(.K9.R.MHGF(G.O^!OWWX!E,).1/%'"0!2*'(%2%)".8!.+!1(.)*"8!'*8*(%)*7!
%! 1..-! .+! +*(("0! "(.8! (*i,"(*2! +.(! )/*! 5"--"8'! .+! 0,-),(*2! /*1%).03)*7! @3! %8!
.B"2%)"#*!7)(*77:!+2.$G0('4(#2.!BC!RQSHRRP:!
;"%,,. 26N. ;"L<')J$(G. 3. R. 0(<U('). 1_! PXXR! \.-*! %82! (*',-%)".8! .+! 7)%(#%)".8H
"82,0*2!%,).1/%'3!"8!)/*!e(.7.1/"-%!+%)!@.23:!Q1>$:1..!C!OTUHOUV:!
;J$*L. 2N. eJH$*. ZN.cH$*. ZN. PHJ#H,J. XN. 6<(Ga%. !KN. ^<<. ZXN. 1H$*. ZN. _(--J$. O9N.
;"L&HG,V. `O. R. 6VH[H. KO! PXXW! E,).1/%'3! (*',-%)*7! %2"1.7*! &%77! %82!
2"++*(*8)"%)".8!"8!&"0*:!f$:.",$B,>1!%!AA@!QQPWHQQQW:!
;%%=HGF.;N._GJ"(.;2N.;LH%*<H$*.O.R.MGH$"L.W!!PXXR!K,11(*77".8!.+!0/%1*(.8*H
&*2"%)*2! %,).1/%'3! "8! )/*! (*8%-! 0.()*B! 2,("8'! %0,)*! 2"%@*)*7! &*--"),7:!
Y"),16$B,%!>?!POQSHPORR:!
1L%GF<G$.!!PXXV!E1.1).7"7!%82!%,).1/%'3F! (*',-%).(3!0.88*0)".87!@*)4**8! )4.!
7,11.7*2-3!2"++*(*8)!1(.0*77*7:!8-2-%2!"!!AB!OHW:!
1%&$-. 2N. XHF(\H. ZN. Z%-LJ+%GJ. 1N. `<%. 6N. ;LH$**<H$. ZN. W%$*. ;N. XH='H$. KN.
X'J%$-#\.4O.R.cJ'(\.Oc!PXXS!K*(%!+(.&!1%)"*8)7!4")/!)31*!P!2"%@*)*7!%82!
8*,(.1%)/3!"82,0*!%,).1/%'3!%82!0.-.0%-"^%)".8!4")/!&").0/.82("%!"8!KLSL!
0*--7:!8&%2-0(/6!A!OTQHOUX:!
! TR!
1-<#H+%,%. ;N.X<+H.!.R.KJV<-LJ+H.0! PXXV%!A/*! (.-*! .+! %,).1/%'3!2,("8'! )/*!
..03)*H).H*&@(3.!)(%87")".8:!8&%2-0(/6!D!OXUTHOXUV:!
1-<#H+%,%. ;N. X<+H. !N. K<GH#H+J. KN. XJ-LJ. 6N. ZH+H+%,%. !. R. KJV<-LJ+H. 0!
PXXV@! E,).1/%'3! "7! *77*8)"%-! +.(! 1(*"&1-%8)%)".8! 2*#*-.1&*8)! .+! &.,7*!
*&@(3.7:!W#"1,#1!B8A!OOUHOPX:!
cH$*.dN.2H,"LU%G).!KN.6LJ.KKN.;"L%(''(G.9N.MG%'%aH.!N.;"L()'.1.R.K%'(\.XW!
PXXW! ;%)*(8%-! 2"%@*)*7! 0%,7*7! &").0/.82("%-! 237+,80)".8! %82! &*".)"0!
2*+*0)7!"8!&,("8*!..03)*7:!+2.$3,)2#'",2.!8B!OTXQHOTOP:!
c\+H$.!N._J$,%.!PN.;L(GJ)H$.2.R.K%'(\.XW!PXXV!>8*H0*--!^3'.)*!)(%87+*(!+(.&!
2"%@*)"0! ).! 8.82"%@*)"0! &.,7*! (*7,-)7! "8! 0.8'*8")%-! &%-+.(&%)".87! %82!
'(.4)/!(*)%(2%)".8!"8!.++71("8':!3,)2#'",2.2/6!AD@!RTTHRTW:!
Z<(. YN. OJ$. ;N. ZH$*. 6N. ^(aJ$(. !O. R. W(J$,V. 0! PXXQ! M*0-"8! O<! %8! %,).1/%'3! '*8*!
*77*8)"%-! +.(! *%(-3! *&@(3.8"0! 2*#*-.1&*8)<! "7! %! /%1-."87,++"0"*8)! ),&.(!
7,11(*77.(:!G'2#$L(%.$8#()$W#"$V$W$8!AEE!OSXUUHOSXVP:!
Y(G$J"#H:`%(,V. KN. K%GGJ-. ;!. R. PG<"(. !c! PXXW! ;%5"8'! %! +"(&! 2*0"7".8F!
&,-)"+%0*)*2!(*',-%)".8!.+!0*--!+%)*!"8!)/*!*%(-3!&.,7*!*&@(3.:!L(%$D1>$C1,1%!
AE!RTUHRUU:!
YL($*.PN.1H$*.1N.1H$*.0N.X<)'J"#H.XN.3L,-<F%.XN.KH._N.KHG,L.O4N.MHGb<LHG.K`.
R. ^(L,%$($. 9! PXXT! J77*8)"%-! (.-*! .+! \ZKH=hO_7.()"8'! 8*B"8! OQ! "8!&.,7*!
2*#*-.1&*8)!%82!(*',-%)".8!.+!*82.03).7"7!238%&"07:!G'2#$L(%.$8#()$W#"$V$W$
8!AEB!OTUUTHOTUVO:!
! TS!
8IC!MJ*<G(.^(*($)-.
MJ*<G(.8IAI. !P("'J$:A.H$).^6B.(f=G(--J%$. J$.GH=H+\"J$.,G(H,().(+FG\%-I! !A*8!
&.,7*!0.8)(.-!@-%7).037)7!4*(*!"80,@%)*2!+.(!QX!/.,(7!"8!*%0/!'(.,1F!e;K>!0.8)(.-!
bEc<!On;!bMc<!.(!Sn;!bCc!(%1%&30"8:!!A/"7!*B1*("&*8)!4%7!(*1*%)*2!Q!)"&*7:!!M*0-"8H
O!*B1(*77".8!"7! "80(*%7*2!"8!%!#%("%@-*!1%))*(8<!4")/!)/*!&.7)!*B1(*77".8!.@7*(#*2!
"8!)/*!)(.1/*0).2*(&!0*--7:!!GCQ!*B1(*77".8!"8!&.,7*!0.8)(.-!@-%7).037)7!"80,@%)*2!
"8!e;K>!be<!8sOXc!.(!Sn;!(%1%&30"8!bJ<!8sOXc:!A/"7!*B1*("&*8)!4%7!0.82,0)*2!Q!
)"&*7:!
.
MJ*<G(. 8I8I. !!<,%=LH*J". H$). H=%=,%,J". G(-=%$-(-. ,%. aHG\J$*. '(a('-. %U. (f"(--.
*'<"%-(I! ! GCQ!*B1(*77".8! "8! *&@(3.7:! !Y*'%)"#*! 0.8)(.-! bEc<! 1/37".-.'"0!S&;!bMc<!
PX&;! bCc<! QS&;! bec! %82! SP&;! bJc! '-,0.7*:! ! C*--! 2*%)/! 2*)*0)".8! %77%3! +.(!
%1.1).7"7:! ! =.7")"#*! 0.8)(.-! .+! eY%7*! )(*%)*2! *&@(3.7! bIc<! 1/37".-.'"0! S&;! bZc<!
PX&;!b]c<!QS&;!b$c<!SP&;!bac!'-,0.7*:!J%0/!'(.,1!0.87"7)*2!.+!%)!-*%7)!QX!*&@(3.7!
%82!)/*!*B1*("&*8)!4%7!(*1*%)*2!Q!)"&*7:!
!
MJ*<G(.8IBI! !`!_4W.H",JaJ,\.H$).H<,%=LH*\.HG(.J$"G(H-().J$.(+FG\%-.(f=%-().
,%. )JHF(,J". ($aJG%$+($,-. F%,L. "#! $"$%. H$). "#! $"&'%I! ! ZE=e]! %0)"#")3! b",$ >">2cF!
*&@(3.7! +(.&! 0.8)(.-! #*(7,7! 7)(*1).^.0"8H"82,0*2! 2"%@*)"0! &.)/*(7! bEc! t1H
#%-,*oX:XXXO:!!ZE=e]!%0)"#")3!b",$>"%'2cF!*&@(3.7!*B1.7*2!).!P:UV&;!#*(7,7!SP&;!
eH'-,0.7*!bMc<!t1H#%-,*oX:XXXS!b8s!%)!-*%7)!SX!+.(!*%0/!'(.,1c:! !
! TT!
!
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Slc2a8 Deficiency in Mice Results in Reproductive and Growth Impairments 
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Abstract  
 SLC2A8, also known as GLUT8, is a facilitative glucose transporter expressed in 
the testis, brain, liver, heart, uterus, ovary and fat.   In this study we examined the effect 
of Slc2a8 deficiency on mouse gamete, preimplantation embryo and implantation 
phenotype, as well as postnatal growth and physiology.  For this model, the 
transcriptional start site and exons 1-4 were targeted and a lack of protein expression was 
confirmed by western immunoblot.  Both sperm cells and oocytes demonstrated abnormal 
metabolism and ATP production, respectively.  The most significant difference between 
wild-type and null mice was the process of embryo implantation.  A lack of SLC2A8 
expression resulted in impaired decidualization, a critical step in the differentiation of 
endometrial stromal cells (ESC), necessary for implantation.  SLC2A8 expression in both 
mouse and human ESCs increases dramatically in response to hormonal changes 
occurring during the process of implantation.  This study is the first to demonstrate that a 
lack of Slc2a8 leads to reproductive defects most likely due to abnormal decidualization 
and impaired implantation.  This phenotype leads to decreased litter size, and smaller 
pups at weaning that continue to display an abnormally small growth phenotype into 
adulthood.  By MRI they displayed decreased body fat and interestingly, they are 
resistant to a diet high in fat and carbohydrates. 
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3.1 Introduction 
 Glucose Transporter 8 (SLC2A8) is a member of the Class III of facilitative 
glucose transporters (SLC2As).  All 14 known SLC2As have shared characteristics 
including 12 transmembrane spanning helices and an exofacial N-linked glycosylation 
site[1], however, SLC2As are unique in tissue localization, kinetics and substrate 
specificity.  More specifically, SLC2A8 has a high affinity for glucose (Km~2mM), 
which can be competed with fructose, galactose and cytochalasin B, indicating that it 
may transport other hexoses[2].    
SLC2A8 is expressed at high levels in the testes and is also found in brain, liver, 
heart, uterus, ovary and fat[2, 3].  Furthermore, SLC2A8 is localized entirely 
intracellular, except in blastocysts where it has been shown to translocate to the plasma 
membrane in response to insulin stimulation[3, 4].  This intracellular localization is 
signaled by a dileucine motif (DEXXXLL), which traffics SLC2A8 to the late 
endosome/lysosome[5].  While research on this SLC2A is ongoing, a known function for 
the SLC2A8 remains elusive. 
Our lab has previously indicated a role for SLC2A8 in pre-implantation embryo 
survival in mice.  Knockdown of Slc2a8 in the embryo, by anti-sense technology, 
resulted in an increase of apoptosis in blastocysts and a decrease in successful 
pregnancies by E14.5[6].  This data, along with data indicating that SLC2A8 is 
translocated to the membrane in response to insulin[3], suggests that SLC2A8 plays an 
important role in embryo development, possibly by facilitation of glucose utilization. 
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Previously published Slc2a8 deficient models, however, do not exhibit embryonic 
lethality, but do display mild reproductive and behavioral phenotypes.  Membrez et al. 
reported a mild brain phenotype consisting of increased proliferation of hippocampal 
cells and an increased P-wave duration in the heart[7].  Another group described a 
phenotype in which deletion of Slc2a8 resulted in reduced sperm motility and ATP and 
behavioral alterations, in particular hyperactivity[8, 9].  These phenotypes are not 
surprising as SLC2A8 is highly expressed in the testes and also in the brain and heart.  
Both groups noted that the heterozygous mating of Slc2a8 mice resulted in lower than 
expected percentage of Slc2a8-/- and Slc2a8+/- pups, potentially resulting from the 
decreased motility observed in the sperm.  Neither of these groups reported changes in 
normal glucose homeostasis or growth at baseline in these models.   
In this paper we detail a distinct phenotype resulting from the creation of a Slc2a8 
null mouse using conventional knockout system, deleting the first four exons including 
the transcription start site globally.  These mice exhibit a more severe reproductive 
phenotype than previous models, as litters born to Slc2a8-/- mating pairs are smaller in 
number than the wild-type controls (Slc2a8+/+).  A role for SLC2A8 in the metabolism 
of both female and male gametes is uncovered as the sperm motility is decreased (which 
is attributed to decreased ATP levels previously[8]), and ATP levels in the oocyte are 
significantly decreased as well.  Additionally, Slc2a8-/- females do not undergo complete 
decidualization of the uterus upon in vivo artificial stimulation, suggesting a role for 
SLC2A8 in the event of implantation and possibly placentation.  Furthermore, in our 
model, SLC2A8 is required for normal growth, as Slc2a8-/- mice are smaller in size than 
their Slc2a8+/+ counterparts.  Finally, although SLC2A8 does not seem to be required 
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for normal glucose homeostasis under basal conditions, the lack of SLC2A8 appears to 
protect the mice from the metabolic conditions induced by high fat feeding.      
 
3.2 Material and Methods 
3.2.1 Generation of Slc2a8 Targeting Construct  
A P1 genomic clone generated from the 129 mouse strain was screened for the presence 
of Slc2a8 by a commercial screening service (Genome Systems, St. Louis, MO).  
Genomic DNA was prepared following the manufacturer’s protocol and used as the 
template for generation of the Slc2a8 targeting construct.  A 2.9kb BglI fragment was 
used for the 5’ arm (forward 5’-CACAAGGCCACATTGTCAGCCCA-3’, reverse 5’-
GCCGCGCTCGCCCGAGCGGC-3’) and a 2.5kb PCR generated fragment for the 3’ 
arm (forward 5’-GGGGGTTCCAGTGCAAGGAAGGGTG-3’ and reverse 5’-
TCGTGGTACCGGTCATTC-3’) (Figure 3.1A).  The targeting vector (pLNTK) 
contains PGK-neo
r
 and HSV-TK genes for positive and negative selection, respectively.   
3.2.2 Generation of Recombinant Slc2a8 ES Clones and Southern Blot Analysis 
RW4 ES cells (Washington University ES Core) were cultured on mitotically inactivated 
mouse embryonic fibroblasts (MEFs) in standard ES medium.  ES cells were 
electroporated with 25 µg of linearized Slc2a8 targeting vector and cultured on MEFs 
resistant to G418. After 24 hr, the medium was supplemented with 400 µg/ml G418 
(GIBCO BRL), and resistant ES clones were isolated after 6 days of selection.  Individual 
clones were expanded, and genomic DNA was prepared and analyzed by southern blot 
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analysis following established methods[10].  Briefly, genomic DNA was digested with 
EcoRV, resolved on 0.8% agarose gels, and transferred to nitrocellulose filters.  Filters 
were hybridized with a 5’ external 
32
P-labeled probe as indicated (Figure 3.1A).  
3.2.3 Western Blot 
Protein was extracted from whole testes digest.  The extracted protein was then run on 
10% SDS-Page gel, transferred to nitrocellulose membrane, then blocked in 5% milk-
TBST, primary antibody specific to the C-terminal of SLC2A8 (created by KHM) was 
used at 1:1000 in 5% milk-TBS-T overnight at 4ºC, goat anti-rabbit secondary was used 
at 1:10,000 in 1% milk/TBS-T for 1 hour, washed and developed by ECL (Amersham).  
The membrane was stripped and re-probed for actin (primary 1:10,000, secondary goat 
anti-mouse 1:10,000) as a loading control.  
3.2.4 Computer Assisted Sperm Analysis (CASA) 
The cauda epididymis was diced, and the sperm were allowed to disperse into the HTF 
embryo max (Millipore) for 10 min at 37ºC.  Motility parameters were measured by 
CASA system (Hamilton-Thorne Research, Beverly, MA, USA).  
3.2.5 Metabolic Analyses 
Mice were primed with 10 IU pregnant mare serum gonadotropin (PMSG) by ip 
injection, and 48 h later cumulus enclosed oocytes were obtained by manual rupturing of 
antral ovarian follicles.  The ATP [11] and Hadh2 [12] microanalytic assays were 
described elsewhere.  The assays are linked to NADPH.  The NADPH by-product is then 
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enzymatically amplified in a cycling reaction, and a byproduct of the amplification step is 
measured in a fluorometric assay. 
3.2.6 Artificial Decidualization 
To generate deciduomas, 7- to 8-wk-old female mice were used and treated as described 
previously[13]. Briefly, mice were ovariectomized and allowed 2 wk for recovery. They 
were then injected with 100 ng 17!-estradiol (E2) (Sigma) for 3 d, rested 2 d, and then 
injected with 10 ng of E2/1 µg of Progesterone (P4) (Sigma) for 3 d. The steroids were 
diluted in sunflower seed oil (Sigma) and injections were all sc, conducted at 1000–1030 
h, with the total volume being 50 µl.  Immediately after the last of the above sensitization 
injections, the right uterine horn received an intraluminal injection of 100 µl of sunflower 
seed oil.  Mice continued to receive 1 mg of P4 sc for up to 4 d.  On the day after the last 
injection the mice were killed, and uterine horns dissected out and weighed.   
3.2.7 Glucose Tolerance and Insulin Tolerance Tests  
Both of these methods were described elsewhere[14].  Briefly, for the glucose tolerance 
test (GTT), mice (n=10 per group) were fasted 16 h prior to an oral gavage of 30% D-
glucose (2 mg/g body wt; Sigma). Blood glucose was measured at 30 min intervals for 
120 min via the tail vein blood on a contour TS glucometer.  For the insulin tolerance test 
(ITT), mice (n=10 per group) were fasted 4 h prior to an intraperitoneal injection of 
bovine insulin (0.75 mU/g body wt; Sigma).  Blood glucose was measured at 15 min 
intervals for 75 min via the tail vein.  For the ITT, the percentage decreases in blood 
glucose from the 0 min time point was calculated. 
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3.2.8 High Fat Diet 
4-week old mice were fed a diet ad libitum consisting of either 58% fat (AIN-76A, Test 
Diet) or 4% fat standard control diet (5053, PicoLab) for a total of 12 weeks.  Mice were 
allowed free access to water and maintain on a 12h light/dark cycle.  Mice were weighed 
weekly. 
3.2.9 Statistical Analysis 
All experiments were completed in triplicate.  Data was analyzed using the student’s t-
test, and significance was reached at p<0.05. 
 
3.3 Results 
3.3.1 Generation of SLC2A8 deficient mice   
 Targeted disruption of the Slc2a8 gene was accomplished via a Slc2a8-targeting 
construct designed to replace the first 4 exons, including the transcriptional start site and 
200bp of 5’ upstream sequence, of the Slc2a8 gene with a neomycin resistance cassette 
(Figure 3.1A).   Genomic DNA isolated from a P1 clone screened for the presence of the 
Slc2a8 gene was used as the template for the construct.  The Slc2a8 gene spans ~9kb and 
consists of 10 exons[15].  Successful targeting was achieved by electroporation of ES 
stem cells with the linearized Slc2a8 targeting construct and subsequent culture in the 
presence of G418.  A total of 750 resistant clones were screened by Southern blot and 1 
recombinant ES clones identified.  A recombinant ES clone was microinjected into 
blastocysts of C57BL/6 mice.  Chimeric mice were screened by Southern blot analysis 
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and founders were intercrossed.  Germline transmission of F1 offspring was confirmed 
by Southern blot analysis (Figure 3.1B).   
We also confirmed deletion of Slc2a8 by reverse-transcriptase PCR in testes, 
heart and liver tissues, which are all known to express Slc2a8.  While Slc2a8 was 
detectable in these tissues in the wild-type animals, no expression was detectable in the 
testes, heart and liver of Slc2a8-/- mice.   
3.3.2 Impaired protein expression in Slc2a8 deficient mice 
 To confirm that the deletion of the Slc2a8 gene resulted in loss of protein 
expression, we performed western blot and immunofluorescence analysis of testes.  
SLC2A8 is most abundantly expressed in the testes, in particular the spermatids, 
spermatozoa and the leydig cells[16].  As illustrated in Figure 3.2A, SLC2A8 is present, 
as expected, in the Slc2a8+/+ mice but is completely absent in testes from Slc2a8-/- 
mice.  Furthermore, immunofluorescence staining of testes also confirmed the absence of 
SLC2A8 protein in the Slc2a8-/- mice (Figure 3.2B).  These results confirm that the 
Slc2a8-/- mice are devoid of SLC2A8 protein.      
3.3.3 Slc2a8-/- mice mating result in smaller litter sizes 
          Other mouse models deficient in Slc2a8 display a reproductive phenotype with less 
than expected percentage of heterozygous and homozygous null mice in Mendelian 
crosses[7, 8].  One group determined that the sperm in their Slc2a8-/- mice was less 
motile than Slc2a8+/+ as a result of decreased ATP and mitochondria membrane 
potential in the sperm[8].  While the matings from their Slc2a8-/- mice produced smaller 
litters, they reported that this phenomenon was neither significant nor investigated.  Our 
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Slc2a8-/- mice exhibit a more severe reproductive phenotype as litters that result from 
Slc2a8-/- mating are significantly smaller in number (~4 pups/litter) than litters from 
Slc2a8+/+ x Slc2a8+/+ mating (~6 pups/litter) (Table 3-I).  To determine whether this 
phenotype was due to a male or female reproductive effect, we mated Slc2a8-/- males or 
females with their Slc2a8+/+ counterpart.  Interestingly, the matings resulted in a 
decreased number of pups similar to the numbers we observed in Slc2a8-/- x Slc2a8-/- 
matings.  This suggests that these mice have a complex reproductive phenotype that may 
stem from an overarching phenotype.  We will address these phenotypes individually in 
this paper.    
3.3.4 Slc2a8-/- males have normal testes histology but exhibit reduced sperm motility 
 SLC2A8 is most abundantly expressed in the testes in both mice and humans.  
While the function of SLC2A8 is unknown, it has been previously suggested that 
SLC2A8 is important for energy metabolism in the sperm[16].  Using hematoxylin and 
eosin (H&E) staining we examined the morphology of testes obtained from Slc2a8-/- 
compared to Slc2a8+/+ mice.  The overall morphology is normal and all cell types are 
present (Figure 3.3A).  In previously reported Slc2a8 deficient mice, no changes in 
morphology were observed but the mice did exhibit a reduction in motility by Computer 
Assisted Sperm Analysis (CASA)[8].  This reduction in motility is consistent with data 
that SLC2A8 is localized mainly to the acrosome region, which is responsible for 
supplying the sperm with energy[16-18].  Therefore, we repeated this assay with the 
Slc2a8-/- mice we generated (Figure 3.3B).  The mice did exhibit a reduction in motility 
with a correlating low number of rapid sperm and an increased number of slow and static 
sperm; however, this data did not reach significance.  While there may be a trend towards 
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a decrease in motility, this phenotype appears to be a minor factor contributing to the 
reduction in litter size observed.   
3.3.5 Slc2a8-/- females have normal ovarian histology but an abnormal metabolic 
profile 
 We also examined the histology of the ovary, as the litter numbers obtained from 
our breeding crosses indicated a female reproductive phenotype as well.  SLC2A8 is 
expressed in the tissues of the female reproductive tract, including the ovaries (and 
oocytes) and the uterus[19, 20].   The histology of ovaries from Slc2a8-/- mice was 
comparable to the Slc2a8+/+ mice ovaries and all cell types were present (Figure 3.3C).  
Additionally, we sought to determine if the oocytes exhibited any metabolic disturbances 
as a result of being devoid of SLC2A8.  Previous data from our lab and others have 
reported that glucose metabolism is critical to the process of meiosis in the oocyte[11, 21, 
22].  A dysregulation of glucose metabolism leading to a decrease in ATP production 
results in oxidative stress and overall poorer outcomes in oocyte development [23, 24].    
Using a microanalytic technique in which we can measure the metabolites of a single 
oocyte, we determined that the ATP content in Slc2a8-/- oocytes is significantly 
decreased compared to Slc2a8+/+ oocytes (~25% less, Figure 3.3D).  These data are 
similar to reported metabolic abnormalities in oocytes obtained from diabetic mice and 
older human patients undergoing IVF[11, 25].   
 To further profile these metabolic abnormalities we examined an important 
enzyme in fatty acid metabolism, hydroxyacyl-CoA dehydrogenase or Hadh2 (formerly 
BOAC).  Our results indicate a decrease in Hadh2 activity in oocytes obtained from 
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Slc2a8-/- compared to wild-type (Figure 3.3E).  In humans, a decrease in this enzyme 
indicates a poorer quality oocyte[25].  Our lab has also published results indicating a 
decrease in this enzyme in oocytes from diabetic mice along with a decrease in ATP due 
to a decrease in AMPK.  This metabolic profile results in a poorer quality oocyte[11].  
Furthermore, it has been hypothesized that Hadh2 is critical to blastocyst development as 
the acyl-CoA dehydrogenase null mouse is embryonic lethal at the morula-to-blastocyst 
transition[26].   
Therefore, we conclude, while overall morphology of the ovary is normal, Slc2a8-
/- oocytes exhibit abnormalities in metabolic pathways potentially leading to a poorer 
quality oocyte and contributing to the reduced litter size seen among the Slc2a8-/- mice. 
3.3.6 In vivo uterine decidualization is affected in Slc2a8-/- mice 
SLC2A8 is expressed in the uterus of both mice and humans.  It is expressed in 
the whole uterus including the stroma, the decidua and both the luminal and glandular 
epithelium[20].  While the function of SLC2A8 in the uterus is unknown, expression of 
Slc2a8 is dramatically increased upon embryo implantation and decidualization, 
indicating that it may play an important role in this process[19].  Therefore, we were 
interested in whether the Slc2a8-/- mice exhibited any disturbance in the uterine 
decidualization process.  Using a rodent specific in vivo artificial decidualization 
technique in which we ovariectomize the mice and supplement hormonal stimuli by 
subcutaneous injection of 17ß-estradiol and progesterone[13], we were able to 
decidualize the uterus in vivo in the absence of an embryo allowing for examination the 
uterus without the interference of the embryo or ovarian effects. 
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The Slc2a8-/- mice had observably smaller decidualized horns compared to the 
Slc2a8+/+ mice (Figure 3.4A).  Moreover, the mass of the decidualized horn compared 
to the internal control was significantly smaller when compared to the Slc2a8+/+ 
counterparts (~35% less, Figure 3.4B).  This indicated that there is a disruption in the 
completion of the decidualization process.  This disruption may lead to the smaller litter 
numbers obtained in the breeding crosses due to abnormal implantation.    
3.3.7 Slc2a8-/- mice weigh significantly less than Slc2a8+/+ mice 
 While other groups have reported no overall change in whole glucose 
homeostasis in mice deficient in the Slc2a8-/- gene, our Slc2a8-/- mice are observably 
smaller than their Slc2a8+/+ counterparts.  The graph in Figure 3.5A details weights of 
the mice starting at 3 weeks of age until 8 weeks of age.  The Slc2a8-/- mice start out 
significantly smaller than the Slc2a8+/+ mice at weaning and continue to be smaller 
despite maturation into adulthood.   
 To determine whether the mice exhibit this small size phenotype starting at 
birth, we weighed the pups at postnatal day 1.  The pup sizes were not significantly 
different between the two groups (Figure 3.5B) suggesting that this phenotype manifests 
later in life.  Next, we examined the daily food intake of these mice to determine if a 
difference in food consumption was responsible for the smaller size phenotype.  The 
Slc2a8-/- mice consumed a similar amount of food (in grams) to the Slc2a8+/+ over 
several weeks (Figure 3.5C).  Finally, we investigated the body composition and fat 
storage and distribution by gonadal fat pad weight and body fat percentage using 
Magnetic Resonance Imaging (MRI).  The gonadal fat pad was smaller (not shown) and 
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the body fat percentage by MRI was similarly less, however neither of these numbers 
reaches significance (Figure 3.6A). 
 Our results indicate that lack of SLC2A8 protein during development is resulting 
in a smaller body size starting with differences observed at weaning.  These differences 
result in a decrease in body fat, although not significant, and are not attributed to food 
intake.   
3.3.8 Slc2a8-/- mice do not exhibit a change in whole body glucose homeostasis  
In order to test whether a dysregulation of whole body glucose homeostasis is 
contributing to the smaller size phenotype observed in the Slc2a8-/- mice, we completed 
both glucose tolerance tests and insulin tolerance tests.  The literature suggests that 
SLC2A8 is not critical in maintaining whole body glucose homeostasis at the basal state.  
Both tests exhibited clearance results similar to Slc2a8+/+ mice (Figures 3.6B & C).  
Therefore, our data also suggests that Slc2a8-/- does not play a role in whole body 
glucose homeostasis under basal conditions.   
3.3.9 Slc2a8-/- mice are resistant to High Fat Diet  
 While SLC2A8 does not appear to be important in overall whole body glucose 
homeostasis during basal conditions, we noticed a distinct phenotype when the mice are 
fed a diet high in fat and carbohydrates (58%) compared to control diet (4%).  We fed the 
mice the diet for a total of 12 weeks and then completed a regimen of assays to determine 
the response of the mice.  We found that the Slc2a8-/- mice did not gain as much weight 
on the diet as the Slc2a8+/+ mice (Figure 3.6D).  This could be attributed to a lack of 
body fat stores, as the Slc2a8-/- exhibited significantly less body fat by MRI (Figure 
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3.6D).  Moreover, the Slc2a8-/- mice fed the high fat diet exhibited improved glucose 
clearance at 60 minutes during the GTT (Figure 3.6E), as well as a normal insulin 
tolerance test as compared to the Slc2a8+/+ fed a high fat diet (Figure 3.6F).  This 
suggests that the Slc2a8-/- mice are somewhat resistant to the effects of a diet high in fats 
and sugars compared to controls.  The mechanism, however, is not clear.  
3.4 Discussion 
SLC2A8 is expressed in insulin-sensitive tissues such as brain and muscle as well 
as other tissues such as ovary, uterus, liver, and heart and it is most highly expressed in 
the testes[2, 3].  Interestingly, unlike other transporters which either reside at the plasma 
membrane (i.e. SLC2A1) or are shuttled there (i.e.SLC2A4), SLC2A8 is found 
intracellularly, with reported localization in the membranes of late endosomes/lysosomes 
and of the ER in the brain[5, 27].  One exception to this localization pattern is in the 
murine blastocyst where SLC2A8 can be triggered to translocate to the plasma membrane 
in response to insulin[3].  While a few papers have reported a Slc2a8 deletion model in 
mice, the function of this unique transporter remains elusive. 
   The Slc2a8-/- mice we generated exhibit a reproductive phenotype resulting in a 
significant decrease in the number of pups per litter.   The Slc2a8-/- mating pairs display 
30% fewer mice per litter as compared to Slc2a8+/+ pairs (Table 3-I).  This phenotype 
is more severe than previously observed in other Slc2a8 deficient models.   This disparity 
could be due to the fact that one conditional knockout was made with a Nestin cre-
knockout model, or due to strain differences or some yet uncovered overarching 
phenotype in the Slc2a8 null mice.  
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 In order to investigate the reproductive phenotype, we examined both gonadal and 
gestational characteristics in the mice.  The male mice exhibit overall normal testes 
morphology, however, the sperm were less motile (Figure 3.3A & B).  This finding is 
supported by previously published models, in which deletion of Slc2a8 resulted in lower 
ATP in the sperm leading to a decrease in sperm motility[8].  Next, we examined the 
ovaries of the female mice.  Again, overall, the morphology was similar to the wild-type; 
however, ATP levels were significantly (25%) lower in the Slc2a8 null oocytes compared 
to wild-type (Figure 3.3C & D).  This discrepancy along with a decrease in Hadh2 
indicates aberrant energy metabolism in the gonad.  Changes in energy metabolism and in 
particular ATP have been associated with poorer quality gametes, which lead to 
unfavorable embryonic outcomes[23, 24, 28].  The reason for this difference in the 
Slc2a8-/- oocytes is not clear but may be related to a decrease in glucose uptake in the 
COC[29]. 
     The process of uterine decidualization is a glucose dependent process, which is 
mediated mainly by SLC2A1[19, 30].  However, our lab and others have shown a 
significant increase in SLC2A8 expression during this process[19].  Therefore, to 
determine if aberrant decidualization is occurring in the Slc2a8-/- mice leading to 
unsuccessful implantation, we examine this process in vivo.  Using a rodent specific 
artificial decidualization technique, we report that the Slc2a8-/- mice exhibit an 
incomplete decidualization of the uterus (Figure 3.4A & B), as demonstrated by a lack of 
artificial decidualization in the mice.  Disruption of this process could explain the 
reproductive failures as a function of the poor implantation of embryos leading to a 
decrease in successful pups per pregnancy.    
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 In conclusion, the Slc2a8 deficient mice generated by our lab display a more 
severe reproductive phenotype then previously reported in other models, leading to a 
smaller litter size.  This difference may be due to the fact that the first null model was a 
Nestin-cre and the second mouse still produced a truncated version of the SLC2A8 
protein[7-9]. We attribute our reproductive findings to potentially both a gonadal and 
uterine phenotype.  The gametes exhibit abnormal energy metabolism in both previous 
reported findings and in our study, in which the oocytes have lower ATP levels.  
Furthermore, we have found a disruption in the uterine decidualization process.  While 
these findings are novel, there may be an overarching phenotype, which is not yet 
elucidated in the SLC2A8 mice we have generated, such as a hormonal dysregulation.     
 While previous Slc2a8 deficient mice models have had no growth disturbances, 
our Slc2a8 deficient mice reveal a need for SLC2A8 in normal growth, as the mice are 
smaller than their wild-type counterparts at 3 weeks of age and into adulthood (in both 
sexes) (Figure 3.5A).  However, this growth phenotype is not associated with a 
dysregulation of overall whole body glucose homeostasis as the ability to clear 
glucose/insulin is similar to wild-type (Figure 3.6B & C).  Furthermore, this small size 
phenotype is not attributed to an increase in food intake as the mice eat similar amounts 
of food to the wild-type (Figure 3.5C). 
 While SLC2A8 does not appear to be necessary for normal whole body glucose 
homeostasis, other SLC2As may be compensating for SLC2A8 masking a role for this 
transporter.  Therefore, we were interested in whether stressing the mice would uncover a 
role for SLC2A8 in this process.  We fed the mice a high fat, high carbohydrate diet for 
12 weeks and assayed the mice for changes in glucose homeostasis.  After 12 weeks on 
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the diet, the Slc2a8 deficient mice exhibited significantly less body fat than the wild-type 
mice (Figure 3.6D).  And interestingly, Slc2a8 deficient mice appear to have an 
improved glucose clearance compared to wild-type as a GTT revealed (Figure 3.6E).  
Additionally, an ITT performed after 12 weeks on the diet showed comparable insulin 
tolerance to mice on normal chow (Figure 3.6F).  Further studies to determine the 
reasons for these differences will need to be completed in the future.  It is possible that 
other SLC2As are upregulated in response to the deletion of Slc2a8 or that there is a 
function for SLC2A8 that is yet to be elucidated leading to these findings.     
 In conclusion, Slc2a8 deficient mice are smaller at 3 weeks of age but exhibit a 
normal glucose homeostasis on normal chow despite a smaller growth trajectory as 
compared to controls that extends into adulthood.  However, when the mice are fed a diet 
consisting of high fat and high carbohydrate, the mice appear resistant to the deleterious 
effects of this diet, observed in the wild-type mice.  Therefore, we conclude that SLC2A8 
is important in normal growth.  While both the reproductive and growth phenotype are 
novel and distinct, we believe that there may be an overall disruption of energy 
metabolism during development, which explains our observations.  It is possible that 
SLC2A8 is present in lysosomal membranes to transport and thus recycle glucose 
residues from degraded glycosylation sites on proteins targeted for autophagy or 
lysosomal degradation.  This function may be critical in processes which require an 
abundance of glucose (and SLC2A8 is shown to be increased), such as uterine 
decidualization and fat differentiation[19, 20, 27, 30, 31], and thus lack of SLC2A8 
expression globally accounts for abnormal decidualization and possibly, subsequent 
placentation and fetal growth; as well as differentiation of adipose cells thus accounting 
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for elimination of lipid accumulation and fat pad mass in the knockout mice.  Further 
studies, however, will need to be completed to fully understand the role of SLC2A8. 
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3.7 Figure Legends 
Figure 3.1 Targeted Disruption of Slc2a8.  (A) Schematic representation of the wild 
type Slc2a8 allele, the targeting vector used, the Slc2a8 targeting construct and the 
targeted Slc2a8 gene are illustrated.  Note the neomycin resistance gene replaces exons 1 
-4 of the Slc2a8 gene.  Additionally, the location of the external 5’ probe used to in 
Southern blot analysis of resistant ES clones and Slc2a8 deficient mice is indicated. 
Abbreviations:  Bgl I (B); HindIII (H); BamHI (BHI); PvuI (P).   (B) Southern blot 
analysis of EcoRV digested genomic tail DNA from the progeny of Slc2a8+/- mice.  (C) 
Reverse transcriptase PCR.  Lane 1: Positive control, 2: marker, 3-5: Slc2a8+/+ testes, 
heart, liver, 6-8: Slc2a8-/- testes, heart, liver. 
Figure 3.2 Impaired protein expression in Slc2a8-/- mice.  (A) Western blot of 
SLC2A8 expression in testes protein.  SLC2A8 is absent in testes from Slc2a8-/- mice.  
(B) Immunofluorescence staining for SLC2A8 in paraffin sectioned testes.  SLC2A8 is 
not expressed in the Slc2a8-/- mice.   
Figure 3.3 Male and Female Gonadal Phenotype.  (A) No changes in overall testes 
morphology observed in Slc2a8-/- mice.  (B) Slc2a8-/- exhibits reduction in sperm 
motility approaching significance.  (C) No changes in overall ovary morphology 
observed in Slc2a8-/- mice.  (D) ATP is significantly decreased in Slc2a8-/- oocytes by 
~25%, n=30.  (E) Hadh2 is significantly decreased in Slc2a8-/- oocytes by ~23%, n=20.    
Figure 3.4 SLC2A8 is required for complete uterine decidualization. (A) 
Representative image of control horn (left) and deciduoma (right) in the Slc2a8+/+ (left) 
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and Slc2a8-/- (right) uterus.  (B) The Slc2a8-/- decidualized horn weighed significantly 
less than the Slc2a8+/+ decidualized horn compared to their respective control horns.   
Figure 3.5 Slc2a8-/- mice exhibit aberrant growth.  (A) Slc2a8-/- mice are smaller at 3 
weeks of age and into adulthood.  Male mice are shown but females exhibit the same 
pattern.  (B) Weights of pups at postnatal day 1 are similar to Slc2a8+/+ mice.  (C) 
Slc2a8-/- mice consume the same amount of food as Slc2a8+/+ indicating this is not 
related to a decrease in calorie consumption.   
Figure 3.6 Overall glucose homeostasis is not affected under normal conditions and 
maintained during high fat feedings.  (A) Slc2a8-/- mice have less body fat by MRI 
than Slc2a8+/+ mice (n.s.).  (B & C) Glucose and insulin tolerance tests are similar to 
Slc2a8+/+ mice.  (D) Slc2a8-/- mice do not gain significant body fat on a high fat diet 
compared to the Slc2a8+/+ mice.  (E & F)  Slc2a8-/- maintains a normal GTT and ITT 
on a high fat diet.   
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4.1 Introduction 
While Slc2a8 deficiency has been studied in several knockout model models, a 
physiological role for this glucose transporter remains elusive.  Due to the unique 
localization of SLC2A8 on the late endosome and lysosome, it is hypothesized that 
SLC2A8 could function as a facilitative lysosomal transporter[1].   
Previously, the literature has recognized the existence of a facilitative lysosomal 
transporter specifically in studies done in rodent liver[2-5].  The transporter described in 
these studies has characteristics similar to SLC2A8.  One apparent difference is the 
proposed affinity for glucose.  The transporter described in the literature has a lower 
affinity for glucose with a Km=22-77mmol/L, while the proposed affinity of SLC2A8 for 
glucose is reported to be around 2mmol/L[2, 5, 6].  However, if SLC2A8 represents a 
lysosomal facilitative transporter for hexoses, then deficiency in this protein could lead to 
detrimental effects manifesting as lysosomal degradation dysfunction.    
The lysosome is the primary organelle responsible for degradation; therefore, 
several other pathways, including endocytosis, phagocytosis and autophagy converge 
with this pathway[7, 8].  Dysfunction in lysosomal degradation leads to the accumulation 
of non-degraded substrates within the lysosome.  This disturbance disrupts cellular 
homeostasis leading to secondary disruptions in biochemical and cellular processes.  
These secondary disruptions result in the severe pathology observed in patients with 
lysosomal storage disorders.   
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Lysosomal Storage Diseases are a class of metabolic disorders that stem from a 
dysfunction in lysosomal degradation.  Although often these disorders are a result of 
mutations or loss in lysosomal hydrolases, other disorders have been linked to 
dysfunction of vesicular trafficking or lysosomal biogenesis.  To date, over 50 different 
genetic diseases have been classified as lysosomal storage disorders[7, 8]. 
Several mouse models have been created to investigate lysosomal storage 
disorders in the laboratory.  Despite differences in enzyme deficiencies, several of these 
mouse models including MPSI, MPSIIIB, MPSVII, Niemann-Pick type A/B and infantile 
neuronal ceriod lipofuscinosis exhibit similarities between phenotypes.  For example, 
these mouse models display a reduced adiposity with seemingly normal adipocyte 
function[9].  Instead, the reduction in adiposity is hypothesized to be a result of a 
negative energy balance stemming from the disruption in lysosomal degradation.  It is 
proposed that the energy required to maintain the dysfunctional lysosomes, as well as the 
energy required to replenish substrates that are inaccessible to the cell, leads to a negative 
balance in energy and a loss of adipose stores[9].  This phenotype of a reduction in 
adiposity with normal adipocyte function is observed in the Slc2a8-/- mice created by our 
lab. 
Due to these similarities in phenotype and the proposed function of SLC2A8, we 
have investigated the intersections between the autophagic and lysosomal pathways and 
SLC2A8 using our Slc2a8-/- mouse model.  Our data is the first to describe SLC2A8 co-
localization with ATG5, a known autophagosomal protein, in the presence of autophagy 
activation.  This co-localization occurs in murine endometrial stromal cells, which have 
been hypothesized to undergo glycogen autophagy to supply the necessary energy to 
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undergo the dynamic processes of decidualization.  Therefore, this co-localization of 
SLC2A8 with the autophagosome, may suggest a role for SLC2A8 in autophagy during 
conditions requiring an abundance of glucose.  Furthermore, using histological, 
microscopic and enzymatic evaluation we have concluded that the Slc2a8 deficient 
mouse model does not display common characteristics of a lysosomal storage disorder 
under basal conditions.  Overall, our data suggests a role for SLC2A8 in energy 
utilization, however, requirement of this facilitative glucose transporter become apparent 
in stress conditions.   
4.2 Material and Methods 
Isolation and culture conditions of primary endometrial stromal cells 
For in vitro decidualization of endometrial stromal cells (ESC), female glucose 
transporter 8 transgenic global over-expressing mice were mated and then sacrificed 4 
days post conception (dpc), and pregnancy was confirmed by flushing dissected uterine 
horns and ostia with Hanks' buffered salt solution and observing for presence of 
blastocysts.  The procedure for ESC isolation is described elsewhere[10].  Briefly, the 
uteri positive for pregnancy were cut into 1mm
3
 pieces and digested in DMEM:F12 
without phenol red and 2g/L Collagenase Type I (Life Technologies, Inc., Gathersburg, 
MD) for 90 min at 37°C, vortexing every 15 min during the incubation.  The solution was 
then passed through a 40!m sieve (BDFalcon, BD Biosciences, San Jose, CA) and 
centrifuged at 1100 rpm for 5 min.  The isolated ESCs were then resuspended in culture 
media (DMEM:F12 without phenol red supplemented with 2% heat-inactivated charcoal 
dextran-stripped calf serum (HyClone, Logan, UT) and 50!g/mL penicillin/streptomycin 
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(Cambrex Bio Science, Walkersville, MD)) and plated in a six-well Costar plate at 
7.5x10
5
 cells per well.  The ESCs were allowed to adhere overnight and then treated for 
24 hours with either culture media or culture media with 5!M Rapamycin to induce 
autophagy activation or DMSO for vehicle control.  
Immunofluorescence staining 
After isolation and culture in the treatment groups for 24 hours, the cells were fixed in 
3% paraformaldehyde in PBS/2%BSA(v/v) for 20 minutes at room temperature, then 
permeabilized in 0.5% TritonX-100 in PBS/2%BSA for 30 minutes.  To block, 5% 
normal goat serum in PBS/2%BSA was used for one hour.  For co-localization studies, 
staining was performed sequentially.  The cells were incubated in the primary antibody 
(1:250) in PBS/2%BSA overnight at 4°C (GLUT8 antibody, created by KHM, Atg5 
antibody, Novus Biologicals, Littleton, Colorado).  The slides were washed three times 
with PBS/2%BSA and then incubated with secondary antibody (Alexa Fluor goat-anti-
rabbit IgG 488, goat-anti-mouse IgG 546, Molecular Probes, Eugene, Oregon) for 45 
minutes at room temperature.  The slides were rinsed three times again and placed in To-
pro®-3-iodide (Molecular Probes, Eugene, Oregon) (1:500) in PBS for 15 minutes.  After 
three more rinses in PBS, the embryos were mounted on slides using Vectashield (Vecta, 
Burlingame, California) and visualized by confocal microscopy.   
Immunolocalization by transmission electron microscopy 
For immunolocalization at the ultrastructural level, samples were fixed in 4% 
paraformaldehyde/0.05% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100mM 
PIPES/0.5mM MgCl2, pH 7.2 for 1 hr at 4˚C.  Samples were then embedded in 10% 
! OOQ!
gelatin and infiltrated overnight with 2.3M sucrose/20% polyvinyl pyrrolidone in 
PIPES/MgCl2 at 4˚C.  Samples were trimmed, frozen in liquid nitrogen, and sectioned 
with a Leica Ultracut UCT cryo-ultramicrotome (Leica Microsystems Inc., Bannockburn, 
IL).  50 nm sections were blocked with 5% FBS/5% NGS for 30 min and subsequently 
incubated with primary antibody (SLC2A8: 1:100, ATG5: 1:200) followed by colloidal 
gold-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., 
West Grove PA).  Sections were washed in PIPES buffer followed by a water rinse, and 
stained with 0.3% uranyl acetate/2% methyl cellulose.  Samples were viewed with a 
JEOL 1200EX transmission electron microscope (JEOL USA Inc., Peabody, MA).  All 
labeling experiments were conducted in parallel with isotype primary antibody controls.  
These controls were consistently negative at the concentration of colloidal gold 
conjugated secondary antibodies used in these studies. 
Autophagosomal number by Electron Microscopy 
For starvation groups, mice were restricted from chow for 48 hours prior to sacrifice.  
Fed and starved mice were then sacrificed and interscapular brown adipose tissue was 
collected.  The tissue was processed as described previously in the Molecular 
Microbiology Imaging Facility at Washington University in St. Louis[11].  The number 
of mitochondria were counted in 25 cells and expressed as the number of mitochondria 
per nucleus.   
b-glucoronidase Assay 
Details concerning the construction of Slc2a8-/- mice have previously been reported 
(chapter 3).  The b-glucuronidase assay was performed in the laboratory of Mark Sands at 
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Washington University, as described previously[12].  Briefly, 500uL of homogenization 
buffer (150mM NaCl, 10mM Tris (pH7.5), 0.2% TritonX-100, 1mM DTT) was used to 
homogenize samples.  After centrifugation, the supernatant was collected into a new tube 
and 2!L of the sample was used.  100!L of 4-methylumbulliferel-B-glucoronidase 
substrate was added to the sample and incubated for 1 hr at 37°C.  After 1 hr, 1mL of 
stop buffer (0.1M Sodium Carbonate) was added.  Fluorescence was read at 365nm 
excitement/448nm emission.     
 
4.3 Results 
 4.3.1 Co-localization of SLC2A8 and ATG5 
 While autophagosomes have been described in the literature beginning in the 
1960s, the field of autophagy has been an active field of investigation the last five years 
due to the identification of the genes responsible for this process[13].  While localization 
studies of SLC2A8 have been undertaken, the co-localization of SLC2A8 with 
autophagic markers has not yet been elucidated in the literature[14].   
Previously our lab has reported the presence of SLC2A8 in the high- and low-
density intracellular membrane fractions of murine primary endometrial stromal cells 
using cellular fractionation[15].  Furthermore, in the Slc2a8-/- mice detailed in the 
previous chapter, we observe an impairment of the uterine decidualization process, 
indicating a role for SLC2A8 in this process.  Therefore, we have investigated the 
localization of SLC2A8 with a known autophagic marker, ATG5 in endometrial stromal 
cells of Slc2a8 transgenic mice that overexpresses SLC2A8 globally.  Using 
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immunofluorescence techniques with antibodies specific to SLC2A8 and ATG5, a 
protein critical for autophagosome formation, we observed a diffuse expression pattern of 
ATG5 under basal conditions, suggesting a low level of autophagosomal formation 
(Figure 4.1).  However, upon activation of the autophagic pathway by treatment of 
rapamycin, the expression pattern of ATG5 changed to a more punctate expression 
pattern signifying the formation of autophagosomes.  Rapamycin suppresses mTOR, a 
negative regulator of the autophagic pathway, thus activating the autophagic pathway.  
Furthermore, upon activation of autophagy, SLC2A8 co-localizes with the ATG5 marker 
in a punctuate patterning.  This co-localization of SLC2A8 with the autophagic pathway 
was confirmed by immuno-electron microscopy.  Using gold-conjugated secondary 
antibodies we again observed SLC2A8 and ATG5 co-localized to autophagosomes in 
endometrial stromal cells treated with rapamycin.  These data suggest that in conditions 
of activated autophagy pathway, such as stress conditions, SLC2A8 is localized to the 
autophagosomal membrane, indicating a possible role for SLC2A8 in autophagy.  One 
explanation for this localization is that SLC2A8 is responsible for hexose transport out of 
the autolysosome after degradation during conditions of elevated autophagy, such as 
stress or nutrient starvation.  This finding, of SLC2A8 on the autophagosomal membrane 
is novel and warrants further investigation into the role of SLC2A8 in autophagy.   
4.3.2 Slc2a8-/- mice have increased mitochondria after starvation 
While SLC2A8 is associated with the autophagosomal membrane, a role for 
SLC2A8 in the autophagosomal pathway remains elusive.  Recently, the phenotype of an 
adipose-specific knockout of Atg7 in mice was detailed[11].  This mouse displays similar 
characteristics to Slc2a8-/- mice with reduced adiposity and resistance to high fat diet.  
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Furthermore, the adipose tissue of the mice is distinct from wild-type as it shows a 
significant increase in mitochondria.  The authors attributed these characteristics to a 
dysregulation of adipogenesis, presumably due to aberrations in autophagy[11, 16].  
Furthermore, a lack of mitochondrial degradation is observed in the hepatocytes of Atg7 
deficient mice upon starvation[16].  These results overall indicate a need for autophagy in 
the clearance of organelles, in particular mitochondria. 
Due to the phenotypic similarities of the autophagy deficient mice and our 
Slc2a8-/- mice and the possible interplay between SLC2A8 and autophagy, we 
investigated the Slc2a8-/- mice for a dysregulation in mitochondrial degradation.  Briefly, 
wild-type and Slc2a8-/- mice were either sacrificed under fed conditions or starved to 
induce autophagy for 48 hours and then sacrificed.  Interscapular brown adipose tissue 
was dissected, then sectioned and viewed using electron microscopy.  The number of 
mitochondria were counted and expressed per nucleus (Figure 4.3).  While the control 
and Slc2a8-/- mice display a similar number of mitochondria during basal conditions, 
upon starvation significantly more mitochondria are observed in the Slc2a8-/- mice, 
suggesting a disruption in degradation. 
4.3.3 Slc2a8-/- mice do not display classical characteristics of lysosomal storage 
disorders 
As previously reported in chapter 3 of this manuscript, Slc2a8-/- mice weigh 
significantly less than their wild-type counterparts at wean age and continue to remain 
smaller into adulthood (Figure 3.5).  This weight difference is associated with a trend 
towards decreased body fat percentage and an increase in lean mass (Figure 3.6 and data 
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not shown, respectively).  Several studies have shown that leptin is circulated at levels 
proportional to body fat.  In accordance, the Slc2a8-/- mice have significantly lower 
leptin levels than control mice (Figure 4.4). 
While the Slc2a8-/- mice have deficiencies in adiposity, characterized by less 
body fat and lower leptin levels, the mice exhibit normal whole body glucose 
homeostasis, as glucose and insulin tolerances were similar to wild-type (Figure 3.6).  
Additionally, fasting insulin levels are normal compared to wild-type mice (data not 
shown).  Furthermore, no significant differences are observed from plasma levels of non-
esterified fatty acids, glucose, triglycerides or cholesterol (Figure 4.5).  This suggests 
that the decreased adiposity of the Slc2a8-/- mice is not a result of dysfunctional 
adipocytes.   
To verify that the reduction in adiposity was not due to a reduced caloric intake, 
food consumption was measured daily for several weeks.  As reported in the previous 
chapter, the Slc2a8-/- mice had a similar daily food intake as their wild-type counterparts 
(Figure 3.5).  Additionally, while Slc2a8-/- mice were more resistant to the effects of a 
high fat diet, as described in chapter 3, displaying less body fat and improved insulin 
tolerance tests compared to control mice fed a high fat diet, the Slc2a8-/- mice still gained 
more weight than animals fed normal chow, suggesting normal adipocyte function in 
Slc2a8-/- mice. 
Because SLC2A8 is localized to the lysosome and the phenotype of the Slc2a8-/- 
mice phenocopies mouse models of lysosomal storage disorders, with a reduced adiposity 
and normal whole body glucose homeostasis, we investigated our Slc2a8-/- mice for 
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characteristics of lysosomal storage disorder (LSD).  The phenotypes of lysosomal 
storage disorders often do not arise until later in life as the accumulation of non-degraded 
substrates causes strain on the normal cell function, which then results in the severe 
phenotype, exhibited in these models.  Due to this often late onset, we studied the 
possibility of lysosomal storage disorder phenotypes in Slc2a8-/- mice and wild-type 
mice that were one year of age or older.   
In some mouse models with lysosomal storage defects, an exaggerated response 
to acoustic startling is reported.  Often times these loud noises will trigger seizures in the 
affected mice[17, 18].  Observation of the Slc2a8-/- mice does not reveal any abnormal 
response to acoustic startling.  However, other abnormal behavioral traits are reported in 
mouse models of LSD, such as altered anxiety[19].  While further behavioral tests were 
not conducted on our model of Slc2a8 deficiency, another Slc2a8-/- mouse model was 
reported to exhibit hyperactivity and a trend towards elevated anxiety[20].  These 
findings along with data detailing increased proliferation in the hippocampus, suggests a 
disruption in normal brain activity in this mouse model.  Therefore, studies are warranted 
to obtain a clear understanding of the role of SLC2A8 in normal brain function.      
As previously mentioned, the accumulation of substrates within lysosomes leads 
to secondary effects in the cell resulting in the severe pathology present in patients with 
lysosomal storage disorders.  In mouse models of lysosomal storage disorders one of the 
common phenotypes present is enlarged organs or hypertrophy[21].  We examined our 
mice for both cardiac hypertrophy and hepatomegaly upon necropsy.  The mice did not 
display signs of cardiac hypertrophy, as the heart size and morphology were similar to the 
wild-type group (data not shown).  To determine if the Slc2a8-/- mice displayed 
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hepatomegaly, we weighed the livers of both groups and reported it as a percentage of 
total mouse weight (Figure 4.6).  The liver weights of the Slc2a8-/- mice were similar to 
the control group.  Therefore, we conclude that our Slc2a8-/- mice do not show signs of 
hypertrophy.   
 In addition to the necropsy, ultra-thin sections of several tissues were examined 
for the presence of lysosomal storage material by transmission electron microscopy.  
Accumulation of non-degraded substrates within the lysosome over time leads to 
lysosomal distention due to an increase in storage material, which is visible by 
transmission electron microscopy[22].  The tissues that were prepared for examination 
included the brain, eye, liver, kidney, heart and testes.  Upon inspection of these tissues, 
the lysosomes did not appear distended but rather similar in size to the wild-type mice 
(Mark Sands, personal communication, data not shown).  This suggests that under basal 
conditions an abundance of storage material is not observed in the lysosomes of Slc2a8 
deficient mice.   
Lastly, we measured the enzyme b-glucuronidase in the brain, liver, spleen and 
testes of the Slc2a8-/- mouse compared to the control mouse.  B-glucuronidase is an 
enzyme responsible for the degradation of glycosaminoglycans[23].  If there were a 
dysfunction of the lysosomal degradation, a secondary elevation in this enzyme may be 
exhibited.  However, in the Slc2a8-/- mice, no differences in b-glucuronidase levels were 
observed comparing the control and Slc2a8-/- groups in the brain, liver and spleen.  
However, in the testes this enzyme was significantly elevated.  Studies of b-
glucuronidase in testes function are limited, however it has been suggested to be 
important in sperm to aid in fertilization, in particular to digest the cumulus cells 
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surrounding the oocyte[24].  The mechanism of elevation in the testes is unclear and 
warrants further investigation.    
 
4.4 Discussion 
 While SLC2A8 has been localized to the lysosomal membrane, localization of 
SLC2A8 with the autophagosome has not been described.  In the data presented in 
Figures 4.1 and 4.2, co-localization with the autophagosomal marker, ATG5 is shown by 
both immunofluorescence and immuno-labelled transmission electron microscopy during 
conditions of activated autophagy.  Localization of SLC2A8 to the autophagosomal 
membrane is novel and implies the necessity for further investigation of SLC2A8 in 
relation to autophagy activation.  One possible explanation for SLC2A8 on the 
autophagosomal membrane in conditions of activated autophagy is to facilitate the 
transport of hexoses, such as glucose, out of the autolysosome for expedited return to the 
cytosol, particularly in conditions that require a high demand for glucose.   
 One process, which requires an abundance of energy in the form of glucose, is 
uterine decidualization.  SLC2A8 may be important in supplying glucose via 
autolysosomal degradation for the decidualization process.  It is evident that glycogen is 
accumulated by the decidual cells prior to decidualization[25].  Furthermore, during the 
decidualization process, an increase in autophagosomal and lysosomal structures are 
observed[26].  Therefore, specifically in the murine endometrial stromal cells, the co-
localization of SLC2A8 during conditions of activated autophagy, may be mimicking this 
physiologically need for an abundance of glucose recycling.  
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It is clear that autophagy is increased in starvation conditions, presumably as a 
pro-survival mechanism.  This increase is considered random, as organelles degraded are 
proportional to protein degradation[27].  In the Slc2a8-/- mice levels of mitochondria are 
similar to fed conditions and significantly more abundant than wild-type starved 
conditions.  It is not clear whether this is an increase in mitochondria or a lack of 
degradation of the organelle.  However, in another Slc2a8-/- mouse model, defective 
mitochondria displaying a lack in condensation and increase in membrane potential were 
evident in the sperm of the mice[29].  Therefore, removal of SLC2A8 may lead to an 
energy imbalance allowing damaged mitochondria to not be degraded[28].    
Due to the unique localization of SLC2A8 on the lysosome, it has been suggested 
that SLC2A8 might represent a lysosomal hexose transporter.  Concurrent with that 
hypothesis, our Slc2a8 deficient mouse described in chapter 3 of this manuscript 
phenocopies several mouse models of lysosomal storage disorders.  These include MPSI, 
MPSIIIB, MPSVII, Niemann-Pick type A/B and infantile neuronal ceriod lipofuscinosis, 
which exhibit reduced adiposity not due to adipocyte dysfunction.  In addition to other 
characteristics including reproductive failures, resistance to effects of high fat diet and an 
overall normal whole body glucose homeostasis.  Therefore, we investigated our Slc2a8 
deficient mouse model using classical lysosomal transporter disorder assays.   
 Despite these similarities, the Slc2a8-/- mice do not display the classical 
characteristics present in lysosomal storage disorders such as an increase in storage 
material or b-glucuronidase.  While the Slc2a8-/- mice do not display apparent 
dysfunctions in lysosomal storage under basal conditions, during conditions that require 
an abundance of energy in the form of glucose and other hexoses, a role of SLC2A8 may 
! OPP!
be revealed.  Therefore, studies investigating SLC2A8 in lysosomal storage should be 
conducting by challenging the Slc2a8-/- mice, particularly in conditions of nutrient 
deprivation. 
However, it is possible that the Slc2a8-/- mice do not display characteristics of 
lysosomal storage disorders, because SLC2A8 is not required for lysosomal hexose 
transport.  In this case, the phenotype of reduced adiposity may be due to another reason.  
For example, there could be an upregulation of other glucose transporters in the lysosome 
or upregulation of SLC2As in the gut, leading to changes nutrient absorbency.  In fact, 
studies conducted in our laboratory suggest an upregulation of SLC2A12 in the gut in the 
absence of Slc2a8, which leads to an increase uptake of fructose.  Ongoing studies are 
being conducted to investigate this possibility.   
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4.7 Figure Legends 
Figure 4.1 SLC2A8 co-localizes with ATG5 upon activation of autophagy.  In 
primary endometrial stromal cells obtained from SLC2A global over-expressing 
transgenic mice, SLC2A8 and ATG5 do not co-localize in basal conditions or in cells 
treated with DMSO (A-B).  However, upon treatment with 5uM Rapamycin for 24hours, 
a localization of SLC2A8 with ATG5 in a puntuacted pattern is observed (C-D). 
Figure 4.2 SLC2A8 and ATG5 are localized to autophagosomes upon autophagy 
activation.  Using immuno-electron microscopy, we observed co-localization of 
SLC2A8 and ATG5 in autophagosomes of murine primary endometrial stromal cells 
obtained from Slc2a8 over-expressing transgenic mice. 
Figure 4.3 Mitochondrial number in Slc2a8-/- brown adipose tissue is not decreased 
upon starvation.  Brown adipose tissue was collected from fed and starved, wild-type 
and Slc2a8-/- mice and examined using electron microscopy.  Mitochondria from 25 
different cells in each group were counted and expressed per nuclei. 
Figure 4.4 Leptin is decreased in Slc2a8-/- mice.  Plasma of Slc2a8-/- mice shows a 
significant decrease in leptin levels compared to wild-type mice.  n=wild-type(15), 
Slc2a8-/-(20) 
Figure 4.5 Slc2a8-/- mice do not display hepatomegaly.  Weights of whole liver were 
recorded at necropsy and compared to total body weight.  The Slc2a8-/- mice did not 
exhibit a difference in liver weight/total body weight compared to wild-type mice. 
n=wild-type(2), Slc2a8-/-(5) 
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Figure 4.6 b-glucuronidase is elevated in the testes, but not other tissues.   The 
enzyme b-glucuronidase was measured in tissues of one-year old wild-type and Slc2a8-/- 
mice.  Elevations of this enzyme compared to wild-type mice were not elevated in the 
brain, liver or the spleen, however, significant elevations was observed when comparing 
the enzyme amount in testes.  
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5.1 Conclusions and Future Directions 
Successful pregnancy relies on the orchestration of many events, several of which 
occur during early pregnancy.  In the field of reproductive biology, it is recognized that 
aberrations in early pregnancy events can lead to adverse reproductive outcomes.   Of 
importance, homeostasis of the surrounding environment of the pre-implantation embryo 
is critical to fetal outcome and the success of a pregnancy.  This is evident in studies of 
diabetes, obesity and poor maternal diet.  Exposure to any of these milieus during the pre-
implantation time period has been shown to have a negative impact on pregnancy and 
fetal outcome[1-3].  Therefore, investigation into the effect of these conditions on pre-
implantation biology is necessary, as the prevalence of these health risks is rising in the 
United States[4].   
Overall, the work presented has expanded our knowledge of the importance of the 
pre-implantation milieu, specifically concerning glucose utilization and energy 
homeostasis as they relate to pregnancy outcome.  In chapter 2, we conclude that 
activation of autophagy results in disparate responses between the cells of the embryo.  
This finding supports the hypothesis of micro-environments within the embryo[5].  
Furthermore, this suggests that the malformations observed in fetuses born to diabetic 
mothers may have resulted from aberrations in autophagy starting as early as the oocyte.  
Further studies to validate this hypothesis should be conducted and are outlined below.  
We present evidence that the pre-implantation embryo alters autophagy in 
response to the external environment.  The embryos respond to stressors including 
rapamycin, a known activator of autophagy, and a hyperglycemic environment, by 
! OQU!
increasing expression of autophagic proteins, identifying autophagy as a pathway for 
survival in the blastocyst.  Furthermore, the embryonic response is differentially activated 
in what appears to be specific cell niches within the embryos.  We hypothesize that this 
differential autophagic response in single cells in the embryo during pre-implantation 
development could affect the subsequent lineage allocation in that cell and its resulting 
daughter cells.  We postulate that this early change in lineage patterning may result not 
only in the growth abnormalities of infants and placentas, but also in malformations 
commonly observed in fetuses from diabetic mothers.   
To test this hypothesis, embryos exposed to rapamycin, an activator of the 
autophagic pathway could be transferred into pseudo-pregnant control female mice and 
the fetal outcome assessed.  In particular, investigation on 14.5 days post-conception 
should include successful pregnancy rate, resorption rate, apparent growth malformations 
and placenta defects.  If maladies were observed similar to the outcomes found with 
embryos exposed to diabetic conditions, this would suggest that aberrant autophagy 
levels during pre-implantation development leads to adverse pregnancy outcomes. 
Previously LC3 (microtubule-associated protein1A/B light chain3), a protein 
associated with the membrane of newly formed autophagosome has not been detected in 
oocytes until after fertilization, however we show a significant difference in activation of 
autophagy in the unfertilized oocyte from diabetic mice[6].   This raises the possibility 
that maternal proteins at this very early stage may be prematurely degraded by 
autophagy, resulting in oocytes deficient in protein and perhaps predisposed to increased 
autophagy and other abnormalities, as we see in the blastocysts from diabetic mice.  
Further studies investigating the effects of autophagic activation in the oocyte should be 
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undertaken.  By treating oocytes with activators of autophagy, such as rapamycin, and by 
performing in vitro fertilization, followed by zygote transfers and then assaying 
reproductive outcome, we can determine whether this increase in autophagy observed in 
diabetic oocytes leads to adverse effects.   Data suggests that cell death can be attributed 
to excessive autophagy[7], therefore, in the oocytes treated with these activators, cell 
death should also be assessed.  Oocytes exposed to rapamycin could be transferred into 
pseudo-pregnant control females and pregnancy outcome should be assessed at 14.5dpc 
including resorption rate, growth malformations and placental defects.   It would be 
expected that aberrant autophagic activation in the oocyte would lead to similar defects 
apparent in diabetic conditions.  
In addition to the investigation of external metabolic changes on the oocyte and 
embryo we also characterized changes in phenotype due to genetic deletion of facilitative 
glucose transporter 8 (Slc2a8-/-).  Unlike classical SLC2As, SLC2A8 is localized 
intracellularly, observed on the endoplasmic reticulum or the lysosome depending on the 
cell type[8, 9].  While research into the function of SLC2A8 is ongoing, a physiological 
role for this facilitative glucose transporter has yet to be elucidated.  In the work detailed 
in chapters 3 and 4, we have uncovered a novel role for SLC2A8 in both reproduction 
and normal growth.   
The Slc2a8-/- mice exhibit a reduction in number of pups per litter.  We conclude 
that loss of Slc2a8 results in affected gametes, embryo and uterine decidualization 
leading to this reduction in litter size.  These findings support the hypothesized role of 
SLC2A8 in energy mobilization as a lysosomal transporter.  Suggesting that during 
processes requiring an abundance of energy, such as early pregnancy events, SLC2A8 
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plays role in recycling the necessary energy in the form of glucose and potentially other 
hexoses to the cell.  On the other hand, these characteristics could stem from an 
overarching global dysregulation in glucose utilization leading to the phenotype 
exhibited.  Proposed experiments to further understand the reproductive phenotype 
follow.          
As mentioned previously, SLC2A8 displays an intracellular localization, which is 
a unique characteristic of class III facilitative glucose transporters.  Provided that this 
localization is unique to these transporters, compensation for loss of SLC2A8 by plasma 
membrane targeted proteins is unlikely.  Furthermore, studies of other Slc2a8-/- mice 
have reported no changes in expression of other studied SLC2As[10].  Cellular fractions 
of mouse endometrial stromal cells (ESC) have confirmed SLC2A8 is not localized to the 
plasma membrane but instead found in the high- and low-density intracellular membrane 
fractions, although the specific intracellular localization is not known[11].  In order to 
understand why the impairment of decidualization is occurring with lack of Slc2a8, we 
should determine intracellular localization of the protein in the ESCs, as this will provide 
insight into the function of SLC2A8 during decidualization.  While decidualization is 
impaired in the Slc2a8-/- mice, pregnancy does occur, therefore the possibility exist that 
other SLC2As may be altered to compensate for the loss of this protein.  For instance, 
upregulation of SLC2A1, a facilitative glucose transporter shown to be critical to the 
decidualization process, may allow for decidualization to continue, albeit at an impaired 
level.  Furthermore SLC2A12, reported to increase in the human endometrial stroma 
during decidualization (but not in the mouse), may be further increased in the event of 
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Slc2a8 deficiency to compensate for this loss[12].  This could explain why the loss of 
Slc2a8 does not result in complete loss of pregnancy.    
Furthermore, the resultant Slc2a8-/- mice display a growth phenotype, as the pups 
are smaller at wean age despite normal whole body glucose homeostasis as evident by 
normal glucose and insulin tolerance tests.  There are several hypotheses for this aberrant 
growth pattern.  One plausible hypothesis is that SLC2A8 is necessary for lysosomal 
transport of glucose, and without it there is a lag or halt of recycling glucose to the cell.  
This theory was considered in chapter 4, in which we found no evidence for lysosomal 
storage defects in the Slc2a8-/- mice under basal conditions, using classical assessments.   
While the Slc2a8-/- mice are not smaller at birth, by wean age, the weights 
compared to wild-type mice are significantly reduced.  Therefore, another viable 
hypothesis is that SLC2A8 functions in normal lactation.  This is proposed in bovine, as 
SLC2A8 is increased 10-fold in the mammary gland in late pregnancy and early lactation 
periods[13].  This hypothesis could be addressed by switching litters of wild-type and 
Slc2a8 deficient mice and recording growth by comparison of body weight.  If the 
Slc2a8-/- mice suckling wild-type milk displayed a growth pattern similar to Slc2a8-/- 
suckled mice, then it is unlikely that lack of SLC2A8 is leading to a phenotype in 
lactation.   
Lastly, studies conducted recently indicate that lack of SLC2A8 leads to an 
upregulation of SLC2A12 in the intestine.  This upregulation of SLC2A12 leads to an 
increase uptake of fructose in these intestinal cells, suggesting a role for SLC2A8 in 
regulating SLCA12 protein (DeBosch and Moley, personal communication).  Therefore, 
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a possible hypothesis remains that SLC2A8 is leading to an altered expression of other 
facilitative glucose transporters and abnormal absorption in the intestine.  Research on 
this hypothesis is currently ongoing.   
In the last chapter, we show evidence for SLC2A8 co-localization with 
autophagosomes during conditions of activated autophagy.  This is a novel and intriguing 
finding which suggests a role for this facilitative glucose transporter in the autophagic 
pathway during activation.  A hypothesis for this interaction is that in conditions of 
activated autophagy, in particular, nutrient deprivation, SLC2A8 is recruited to the 
autophagosome membrane to transport glucose out of the autolysosome.  Further studies 
are needed to determine if SLC2A8 is recruited to the autophagosome under conditions 
of nutrient deprivation.  Additionally, we could investigate autophagic marker expression 
in basal and stressed conditions in the Slc2a8-/- mice to determine if lack of SLC2A8 
causes aberrant autophagy. 
 Due to the unique localization of SLC2A8 on the lysosome, lysosomal transport is 
potentially altered in Slc2a8-/- mice.  The Slc2a8-/- mice display similar phenotypes to 
several LSD model mice including a reduced adiposity with seemingly normal adipocyte 
function and normal whole body glucose homeostasis.  Data in the literature suggests that 
glucose and other hexoses may be transported out of the lysosome by free diffusion, 
however the presence of a facilitative lysosomal transporter is also been confirmed.  
Therefore, in instances that require an abundance of recycled glucose, such as 
differentiation and growth or in aberrant conditions such as starvation, the need for a 
facilitative transporter of glucose out of the lysosome may be required.  So, while our 
findings conclude that the Slc2a8-/- mice do not display classical characteristics of 
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lysosomal storage disorders in a basal state, investigation during conditions of stress may 
lead to perturbations in this pathway.  Examination of the lysosomal degradation pathway 
after exposure to starvation or calorie restriction may reveal a role for SLC2A8 in 
lysosomal transport under these conditions.   
  
In summation, the novel findings in this dissertation expand our knowledge of 
glucose utilization and energy homeostasis in early pregnancy events.  These findings 
provide a more detailed picture of the importance of normal glucose transport to fetal 
outcome.  Overall, this knowledge may one day be translatable to clinical management 
surrounding pregnancy and fertility issues. 
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